<SEC-DOCUMENT>0001104659-22-057017.txt : 20220506
<SEC-HEADER>0001104659-22-057017.hdr.sgml : 20220506
<ACCEPTANCE-DATETIME>20220506163106
ACCESSION NUMBER:		0001104659-22-057017
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20220503
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220506
DATE AS OF CHANGE:		20220506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		22901727

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2214421d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:bsx="http://bostonscientific.com/20220503">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_bsx_bostonscientific.com_20220503 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20220503_20220503 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0000885725 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_071_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\EntityInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-05-03to2022-05-03" name="dei:EntityCentralIndexKey">0000885725</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-05-03to2022-05-03" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="bsx-20220503.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-05-03to2022-05-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-03</xbrli:startDate>
        <xbrli:endDate>2022-05-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-032022-05-03_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-03</xbrli:startDate>
        <xbrli:endDate>2022-05-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-032022-05-03_custom_SeniorNoteDue2027Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNoteDue2027Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-03</xbrli:startDate>
        <xbrli:endDate>2022-05-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-032022-05-03_custom_A550MCPSSeriesAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-03</xbrli:startDate>
        <xbrli:endDate>2022-05-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0"></p>

<p style="margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: none"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20220503__20220503_zHVQQepi2iBl"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF THE<br />

SECURITIES EXCHANGE ACT OF 1934</b>&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="background-color: White">Date of
Report (Date of earliest event reported): May </span>6<span style="background-color: White">, 2022 (</span><span id="xdx_909_edei--DocumentPeriodEndDate_c20220503__20220503_zYncg9tIo3V5"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May
3, 2022</ix:nonNumeric></span>)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90F_edei--EntityRegistrantName_c20220503__20220503_zyCTd9pZDBLa"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" name="dei:EntityRegistrantName">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
 charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-top: 2pt; text-align: center; width: 34%"><span style="font: 10pt Times New Roman, Times, Serif; text-transform: none"><b><span style="text-decoration: underline"><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20220503__20220503_z3Gy4knT78H"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></span></td>
    <td style="padding-top: 2pt; width: 1%">&#160;</td>
    <td style="padding-top: 2pt; text-align: center; width: 31%"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><b><span id="xdx_90B_edei--EntityFileNumber_c20220503__20220503_z1S4hZ7Oxap"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" name="dei:EntityFileNumber">1-11083</ix:nonNumeric></span></b></span></span></td>
    <td style="padding-top: 2pt; width: 1%">&#160;</td>
    <td style="padding-top: 2pt; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20220503__20220503_z1ADRQQbSDLf"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" name="dei:EntityTaxIdentificationNumber">04-2695240</ix:nonNumeric></span></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 2pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other<br />
 jurisdiction
    of incorporation)</span></td>
    <td style="padding-top: 2pt">&#160;</td>
    <td style="padding-top: 2pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission<br />
 file
    number)</span></td>
    <td style="padding-top: 2pt">&#160;</td>
    <td style="padding-top: 2pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS employer<br />

    identification no.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-top: 2pt; text-align: center; width: 54%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="xdx_903_edei--EntityAddressAddressLine1_c20220503__20220503_zI3UVu9sFiM7"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" name="dei:EntityAddressAddressLine1">300 Boston Scientific Way</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressCityOrTown_c20220503__20220503_zZgNt6OMenng"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" name="dei:EntityAddressCityOrTown">Marlborough</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20220503__20220503_zdERPqdOGsta"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span></span></b></span></td>
    <td style="padding-top: 2pt; width: 1%">&#160;</td>
    <td style="padding-top: 2pt; text-align: center; width: 45%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="xdx_907_edei--EntityAddressPostalZipCode_c20220503__20220503_zjoZ0jE8FSn6"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" name="dei:EntityAddressPostalZipCode">01752-1234</ix:nonNumeric></span></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top; padding-top: 2pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</span></td>
    <td style="vertical-align: bottom; padding-top: 2pt">&#160;</td>
    <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 3pt; padding-left: 3pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip code)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant's telephone number, including area
code: <b><span style="text-decoration: underline">(<span id="xdx_900_edei--CityAreaCode_c20220503__20220503_zff3MtRFpzj7"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" name="dei:CityAreaCode">508</ix:nonNumeric></span></span></b><b><span style="text-decoration: underline">) <span id="xdx_902_edei--LocalPhoneNumber_c20220503__20220503_zrw1DLiBpXH1"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" name="dei:LocalPhoneNumber">683-4000</ix:nonNumeric></span></span></b></p>

<p style="font: 2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--WrittenCommunications_c20220503__20220503_zz79JTcz0kOg"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 97%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_edei--SolicitingMaterial_c20220503__20220503_zO0g8EXVdT3a"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--PreCommencementTenderOffer_c20220503__20220503_zxP7MVbW33N5"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20220503__20220503_zy1aBA5NqN1"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Emerging growth company&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20220503__20220503_zkakkaVrUFi7"><ix:nonNumeric contextRef="From2022-05-03to2022-05-03" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; width: 37%; padding-top: 2pt; padding-bottom: 2pt; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="border-top: Black 1pt solid; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; width: 26%; padding-top: 2pt; padding-bottom: 2pt; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol</b></span></td>
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; width: 35%; padding-top: 2pt; padding-bottom: 2pt; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center"><span id="xdx_901_edei--Security12bTitle_c20220503__20220503__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zUMYoJND3h2a"><ix:nonNumeric contextRef="From2022-05-032022-05-03_us-gaap_CommonStockMember" name="dei:Security12bTitle">Common Stock, $0.01 par value per share</ix:nonNumeric></span></td>
    <td style="border-top: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center"><span id="xdx_900_edei--TradingSymbol_c20220503__20220503__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zjILvKxwlRi8"><ix:nonNumeric contextRef="From2022-05-032022-05-03_us-gaap_CommonStockMember" name="dei:TradingSymbol">BSX</ix:nonNumeric></span></td>
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: center"><span id="xdx_90A_edei--SecurityExchangeName_c20220503__20220503__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zW73IsRRRsBh"><ix:nonNumeric contextRef="From2022-05-032022-05-03_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><span id="xdx_90B_edei--Security12bTitle_c20220503__20220503__us-gaap--StatementClassOfStockAxis__custom--SeniorNoteDue2027Member_z8mpwsifth89"><ix:nonNumeric contextRef="From2022-05-032022-05-03_custom_SeniorNoteDue2027Member" name="dei:Security12bTitle">0.625% Senior Notes due 2027</ix:nonNumeric></span></td>
    <td style="border-top: Black 1pt solid">&#160;</td>
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><span id="xdx_90A_edei--TradingSymbol_c20220503__20220503__us-gaap--StatementClassOfStockAxis__custom--SeniorNoteDue2027Member_zvubzw2bhB95"><ix:nonNumeric contextRef="From2022-05-032022-05-03_custom_SeniorNoteDue2027Member" name="dei:TradingSymbol">BSX27</ix:nonNumeric></span></td>
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><span id="xdx_903_edei--SecurityExchangeName_c20220503__20220503__us-gaap--StatementClassOfStockAxis__custom--SeniorNoteDue2027Member_z8trmJPX2L3b"><ix:nonNumeric contextRef="From2022-05-032022-05-03_custom_SeniorNoteDue2027Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>

<tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 10pt; vertical-align: top; width: 37%; text-align: center; padding-left: 10pt"><span style="font-size: 10pt"><span id="xdx_90B_edei--Security12bTitle_c20220503__20220503__us-gaap--StatementClassOfStockAxis__custom--A550MCPSSeriesAMember_zbmy2qyBZP5d"><ix:nonNumeric contextRef="From2022-05-032022-05-03_custom_A550MCPSSeriesAMember" name="dei:Security12bTitle">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: top; width: 26%; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20220503__20220503__us-gaap--StatementClassOfStockAxis__custom--A550MCPSSeriesAMember_zVPgQpddmRf4"><ix:nonNumeric contextRef="From2022-05-032022-05-03_custom_A550MCPSSeriesAMember" name="dei:TradingSymbol">BSX PR A</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 35%; text-align: center"><span style="font-size: 10pt"><span id="xdx_905_edei--SecurityExchangeName_c20220503__20220503__us-gaap--StatementClassOfStockAxis__custom--A550MCPSSeriesAMember_zjeag0knkw31"><ix:nonNumeric contextRef="From2022-05-032022-05-03_custom_A550MCPSSeriesAMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 5.02</b></td><td><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(e) Compensatory Arrangements of Certain Officers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As part of the ongoing evaluation of its executive compensation
programs, the Executive Compensation and Human Resources Committee of the Board of Directors of Boston Scientific Corporation (the "Company"), reviewed the existing form of Change in Control Agreement for
executive officers below the chief executive officer level and approved certain modifications to better align executive compensation
with increasing stockholder value following a change in control.&#160;On May 3, 2022, the Executive Compensation and Human Resources
Committee approved changes to the form of Change in Control Agreement for  executive officers below the chief executive officer
level (&#8220;Revised Change in Control Agreements&#8221;). The Revised Change in Control Agreements provide for a cash severance payment amount following a change in control (as defined under the
Revised Change in Control Agreements) of two times base salary and bonus, as calculated under the agreement, instead of three times base
salary and bonus, as provided for under the agreements prior to amendment.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company intends to ask each of its eligible executive officers to execute and agree to the terms of the Revised Change in Control Agreements
upon the expiration of their existing Change in Control Agreements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A copy of the form of Revised Change in Control Agreement is filed as Exhibit 10.1 hereto and incorporated by reference. This summary
does not purport to be complete and is subject to and qualified in its entirety by reference to the full text of the form of Revised Change
in Control Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 5.07</b></td><td><b>Submission of Matters to a Vote of Security Holders.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td>The Company held the Annual Meeting <span style="background-color: white">in a virtual-only format via live webcast.</span>&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span><span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>The
final voting results on each of the matters submitted to a vote of stockholders at the Annual Meeting are set forth below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span><span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>All
ten director nominees were elected to the Board for a one-year term to hold office until the Company&#8217;s 2023 Annual Meeting of Stockholders
and until their successors have been elected and qualified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><b>Nominee</b></td><td style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>For</b></td><td style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td><td style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Against</b></td><td style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td><td style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Abstain</b></td><td style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td><td style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Broker Non-Votes</b></td><td style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 39%; text-align: left">Nelda J. Connors</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center">1,184,941,114</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center">25,966,939</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center">795,391</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: center">33,421,847</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Charles J. Dockendorff</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,101,021,316</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">109,957,955</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">724,173</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">33,421,847</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Yoshiaki Fujimori</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,188,823,285</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">22,159,948</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">720,211</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">33,421,847</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Donna A. James</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,180,887,240</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">30,080,716</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">735,488</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">33,421,847</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Edward J. Ludwig</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,177,537,388</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">33,454,632</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">711,424</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">33,421,847</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Michael F. Mahoney</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,130,551,001</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">75,373,897</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">5,778,546</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">32,421,847</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">David J. Roux</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,164,971,131</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">44,614,802</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2,117,511</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">33,421,847</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">John E. Sununu</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,171,099,286</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">39,832,624</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">771,534</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">33,421,847</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">David S. Wichmann</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,191,954,790</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">19,022,372</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">726,282</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">33,421,847</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Ellen M. Zane</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,122,386,967</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">88,625,966</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">690,511</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">33,421,847</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span><span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;</span>The
advisory vote on the compensation for the Company&#8217;s &#8220;Named Executive Officers&#8221; as disclosed in the Company&#8217;s
proxy statement for the Annual Meeting was approved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker&#160;Non-Votes</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10.1pt; text-align: center; text-indent: -10.1pt">1,085,193,759&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">124,111,318&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">2,398,367&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">33,421,847&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span><span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;</span>The
appointment of Ernst&#160;&amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the 2022 fiscal year
was ratified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-indent: -27pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="width: 3%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 3%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10.1pt; text-align: center; text-indent: -10.1pt">1,185,136,735&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">59,317,844&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">670,712&#160;</td>
    <td style="background-color: White; vertical-align: bottom; text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;(4)</span><span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;</span>The
amendment and restatement of the Company&#8217;s 2006 Global Employee Stock Ownership Plan to, among other things, rename the plan as
the Company&#8217;s Employee Stock Purchase Plan and add an additional 10,000,000 shares to the plan, was approved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-indent: -27pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Abstain</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broker&#160;Non-Votes</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10.1pt; text-align: center; text-indent: -10.1pt">1,208,792,725&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">2,434,876&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">475,843&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">33,421,847&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 9.01</b></td><td><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="padding-left: 10pt; text-indent: -10pt; width: 12%"><span style="text-decoration: underline; font-size: 10pt"><b>Exhibit No.</b></span><b> <span style="text-decoration: underline"></span></b></td>
  <td style="padding-left: 10pt; text-indent: -10pt"><span style="text-decoration: underline"><b>Description </b></span></td></tr>
<tr style="vertical-align: top">
  <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
  <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td></tr>

<tr style="vertical-align: top">
  <td style="padding-left: 10pt; text-indent: -10pt"><a href="tm2214421d1_ex10-1.htm" style="color: Blue; -sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
  <td style="padding-left: 10pt; text-indent: -10pt"><a href="tm2214421d1_ex10-1.htm" style="color: Blue; -sec-extract: exhibit">Form of EC Non-CEO Change in Control Agreement</a></td></tr>
<tr style="vertical-align: top">
  <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
  <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td></tr>

<tr style="vertical-align: top">
<td><a href="tm2214421d1_ex10-2.htm" style="color: Blue; -sec-extract: exhibit">10.2</a></td><td><a href="tm2214421d1_ex10-2.htm" style="color: Blue; -sec-extract: exhibit">Boston Scientific Corporation Employee Stock Purchase Plan, Amended and Restated Effective as of July 1, 2022</a></td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td></tr>

<tr style="vertical-align: top">
  <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt">104</span></td>
  <td style="padding-left: 10pt; text-indent: -10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 4.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 4.75in"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 4.75in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 6, 2022</span></td>
<td>&#160;</td>
<td><b>BOSTON SCIENTIFIC CORPORATION</b></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 51%">&#160;</td>
<td style="width: 4%">By:</td>
<td style="border-bottom: Black 1pt solid; width: 45%">/s/ Susan Thompson</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Susan Thompson</span></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President, Chief Corporate Counsel and Assistant Secretary</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kNFKwzAUhp9g73Aoele6NFKE3tWqQ9xGWccQxIu4nmlYm1OSdLpH8i1NUsULtxAI4Xzf+ZMTRXE0o3vZooanm9Uc1tj1rbAIK9yhRrVFR5QPjzm4c4Vv0lgtlA3XX7Ek56BzsiTlwhUCepAGmxwYn/J0yjmkLE85VIto4uslqZ1sUFkpWhCqgUpTryVaoY9jh7X4JEXdMURtUBtJKoc0YWP5Czhz/ZZ0EB+k9wbm8zKaxGFNopmmofcxg7HUwV2Lncsyo/q3w1O2gclrVJL0kizeDsgZv15g94raAYzxK5YWP8EjBx6EZkDwKDyP8MuJvm46Hana0nbPEpZWQm9EO2CFun4XGs+kjBYELYYLb0IvNBy8C72buvH2ibwiy9iirOoa3ThNcaZ/lmTsEjwXw0hC8e8X34YIm4c= -->


</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2214421d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left"><IMG SRC="tm2214421d1_ex10-1img01.jpg" ALT="">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"><IMG SRC="tm2214421d1_ex10-1img02.jpg" ALT="">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[FORM&nbsp;OF EC NON-CEO CHANGE IN CONTROL AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[INSERT NAME]&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[INSERT ADDRESS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Re: Change in Control Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear [INSERT FIRST NAME]:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Boston Scientific Corporation (the &ldquo;<I>Company</I>&rdquo;)
considers it essential to the best interests of its stockholders to foster the continuous employment of key management personnel. Further,
the Board of Directors of the Company (the &ldquo;<I>Board</I>&rdquo;) recognizes that the possibility of a change in control exists,
and that such possibility, and the uncertainty and questions that it may raise among management, may result in the departure or distraction
of management personnel to the detriment of the Company and its stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Board has determined that appropriate steps
should be taken to reinforce and encourage the continued attention and dedication of members of the management of the Company, including
yourself, to their assigned duties without distraction in the face of potentially disturbing circumstances arising from any possible
change in control of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">In order to induce you to remain in the employ of
the Company, the Company agrees that you shall receive the severance benefits set forth in this letter agreement (this &ldquo;<I>Agreement</I>&rdquo;)
in the event your employment with the Company is terminated subsequent to a Change in Control (as defined herein) under the circumstances
described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Term
of the Agreement</U>. Sections 2, 3, 4, 5 and 6 of this Agreement shall only be applicable if a Change in Control occurs during the period
beginning on [INSERT DATE], subject to the completion of execution of this Agreement, (the &ldquo;<I>Effective Date</I>&rdquo;) and ending
on the earlier of the (i)&nbsp;third anniversary of the Effective Date and (ii)&nbsp;termination of your employment with the Company
for any reason prior to a Change in Control (the &ldquo;<I>Term</I>&rdquo;). If a Change in Control does not occur during the Term, this
Agreement will automatically terminate at the end of the Term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Termination
Following a Change in Control</U>. If a Change in Control occurs at any time during the Term, you will be entitled to the benefits provided
in Section&nbsp;3 hereof upon the subsequent termination of your employment by the Company without Cause (as defined herein) or by you
for Good Reason (as defined herein) during the two-year period following such Change in Control (the &ldquo;<I>Covered Period</I>&rdquo;).
Any purported termination of your employment by the Company or by you shall be communicated by a Notice of Termination to the other party
hereto in accordance with Section&nbsp;8 hereof. For purposes of this Agreement, (i)&nbsp;references to termination of employment mean
a &ldquo;separation from service&rdquo; (as defined in Section&nbsp;1.409A-1(h)&nbsp;of the Treasury Regulations) from the Company, and
(ii)&nbsp;a &ldquo;<I>Notice of Termination</I>&rdquo; shall mean a written notice which shall indicate the specific termination provision
or provisions in this Agreement relied upon and shall set forth in general terms the facts and circumstances claimed to provide a basis
for termination of your employment under the provision so indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Compensation
Upon Termination</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Severance
Benefits</U>. If your employment by the Company shall be terminated during the Covered Period by the Company without Cause or by you
for Good Reason, then you shall be entitled to the following benefits:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Severance
Payments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">(1)&nbsp; <U>Amount of Payment</U>. The
Company shall pay you in cash the full amount of any earned but unpaid base salary through the Date of Termination at the rate in effect
at the time of the Notice of Termination, plus a cash payment for all unused vacation time which you may have accrued as of the Date
of Termination. The Company shall also pay you in cash a pro rata portion of the annual bonus for the year in which your employment terminates,
calculated on the basis of your target bonus for that year and on the assumption that all performance targets have been or will be achieved.
In addition, the Company shall pay you in a cash lump sum, an amount (the &ldquo;<I>Severance Payment</I>&rdquo;) equal to two times
the sum of (A)&nbsp;your base salary on the Termination Date (without giving effect to any salary reductions which satisfy the definition
of &ldquo;<I>Good Reason</I>&rdquo;) and (B)&nbsp;the greater of (x)&nbsp;the most recent bonus paid to you (which shall be deemed to
be the sum of (I)&nbsp;the annual cash bonus amount most recently paid to you and (II)&nbsp;the grant date fair value of any equity awards
granted to you in lieu of annual bonus compensation within the immediately preceding year) and (y)&nbsp;your target bonus in effect for
the year in which the Change in Control occurred (calculated assuming that all performance targets have been or will be achieved). The
Severance Payment shall be in lieu of any other severance payments which you are entitled to receive under any other severance pay plan
or arrangement sponsored by the Company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">(2)&nbsp; <U>Timing of Payment</U>. Subject
to Section&nbsp;3(b), the Company shall pay the amounts due to you under this Section&nbsp;3(a)(i)&nbsp;on the 60<SUP>th</SUP> day following
the Date of Termination, <I>provided</I> that you execute, and do not revoke, a Release Agreement in the form attached as Exhibit&nbsp;A
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Benefit
Continuation</U>. Subject to your compliance with the non-solicitation and confidentiality provisions described in Section&nbsp;6, you
and your eligible dependents shall continue to be eligible to participate during the Benefit Continuation Period (as hereinafter defined)
in the medical, dental, health, life and other welfare benefit plans and arrangements applicable to you immediately prior to your termination
of employment on the same terms and conditions in effect for you and your dependents immediately prior to such termination; provided
that the provision of such benefits in each calendar year during the Benefit Continuation Period does not affect the provision of such
benefits in any other calendar year during the Benefit Continuation Period. For purposes of the previous sentence, &ldquo;<I>Benefit
Continuation Period</I>&rdquo; means the period beginning on the Date of Termination and ending on the earlier to occur of (i)&nbsp;the
third anniversary of the Date of Termination and (ii)&nbsp;the date that you and your dependents are eligible for coverage under the
plans of a subsequent employer which provide substantially equivalent or greater benefits to you and your dependents. The right to participate
in the benefit plans under this Section&nbsp;3(a)(ii)&nbsp;is not subject to liquidation or exchange for any other benefit;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Legal
Fees and Expenses</U>. The Company shall also pay you in cash all legal fees and expenses, if any, incurred by you in contesting or disputing
any such termination or in seeking to obtain or enforce any right or benefit provided by this Agreement if such expenses are incurred
on or prior to the December&nbsp;31 of the second calendar year following the calendar year in which the Date of Termination occurs,
such payment(s)&nbsp;to be made on or before the December&nbsp;31 of the third calendar year following the calendar year(s)&nbsp;in which
the Date of Termination occurs; <I>provided, however,</I> that the amount of the payments and reimbursements under this Section&nbsp;3(a)(iii)&nbsp;shall
not exceed $100,000; and <I>provided, further</I>, that no such legal fees or expenses shall be reimbursed if it is determined by the
applicable arbitral panel or other tribunal that your claim is entirely without merit. Furthermore, nothing shall prohibit the arbitral
panel or other tribunal from awarding legal fees in excess of $100,000 if, in the interests of fairness and equity, the arbitral panel
or other tribunal deems such award appropriate. The right to receive payments and reimbursements under this Section&nbsp;3(a)(iii)&nbsp;is
not subject to liquidation or exchange for any other benefit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Specified
Employee</U>. Notwithstanding anything to the contrary in this Agreement, if you are a &ldquo;specified employee&rdquo; as hereinafter
defined at the time of the Date of Termination, any and all amounts payable in connection with your termination of employment (including
amounts payable under this Section&nbsp;3) that constitute deferred compensation subject to Section&nbsp;409A of the Code, as determined
by the Executive Compensation and Human Resources Committee (the &ldquo;<I>Committee</I>&rdquo;) in its sole discretion, and that would
(but for this sentence) be payable within six months following the Date of Termination, shall instead be paid on the date that follows
the Date of Termination by six months and one day (the &ldquo;Specified Employee Payment Date&rdquo;). The provision of benefits pursuant
to Section&nbsp;3(a)(ii)&nbsp;that constitute deferred compensation under Section&nbsp;409A of the Code will not be provided in-kind
during the first six months following the Date of Termination, but rather will be continued by your payment of any applicable premiums
for which you will be reimbursed on the Specified Employee Payment Date. The provision of in-kind benefits will commence on the Specified
Employee Payment Date in accordance with Section&nbsp;3(a)(ii). For purposes of this Agreement, the term &ldquo;specified employee&rdquo;
means an individual who is determined by the Committee to be a specified employee as defined in Section&nbsp;409A(a)(2)(B)(i)&nbsp;of
the Code. The Committee may, but need not, elect in writing, subject to the applicable limitations under Section&nbsp;409A of the Code,
any of the special elective rules&nbsp;prescribed in Section&nbsp;1.409A-1(i)&nbsp;of the Treasury Regulations for purposes of determining
 &ldquo;specified employee&rdquo; status. Any such written election shall be deemed part of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Mitigation</U>. You shall not be required to mitigate the amount of any payment or benefit provided for in this Section&nbsp;3 by seeking
other employment or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Reduction
of Severance Payments if Reduction Would Result in Greater After-Tax Amount</U>. Notwithstanding anything herein to the contrary, in
the event that you receive any payments or distributions, whether payable or distributed or distributable pursuant to the terms of this
Agreement or otherwise, that constitute &ldquo;parachute payments&rdquo; within the meaning of Section&nbsp;280G of the Code, and the
net after-tax amount of the parachute payment, including any applicable excise taxes under Section&nbsp;4999 of the Code, is less than
the net after-tax amount if your aggregate payment were three times your &ldquo;base amount&rdquo; (as defined in Section&nbsp;280G(b)(3)&nbsp;of
the Code) less $1.00, then the Severance Payments shall be sufficiently reduced to ensure that the aggregate value of the amounts constituting
the parachute payment will equal three times your base amount, less $1.00. The determinations to be made with respect to this Section&nbsp;3(d)&nbsp;shall
be made by an Accounting Firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">4.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Equity
Incentive Awards</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Options</U>.
All outstanding options granted to you under the Company&rsquo;s equity incentive plans shall vest and become exercisable if your employment
is terminated without Cause or you resign your employment for Good Reason during the Covered Period; <I>provided, however</I>, that if
the surviving or acquiring entity does not provide for the substitution or assumption of the outstanding options, your outstanding options
shall immediately become exercisable upon a Change in Control. If no such termination or resignation occurs during the Covered Period
and the outstanding options are substituted or assumed, your outstanding options shall continue to vest pursuant to the terms of the
Company&rsquo;s equity incentive plans or applicable award agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Restricted
Stock and Deferred Stock Unit Awards</U>. All restricted stock and deferred stock unit awards granted to you under the Company&rsquo;s
equity incentive plans shall become free from restriction if your employment is terminated without Cause or you resign your employment
for Good Reason during the Covered Period; <I>provided, however</I>, that if the surviving or acquiring entity does not provide for the
substitution or assumption of outstanding restricted stock or deferred stock unit awards, your outstanding restricted stock and deferred
stock unit awards shall immediately become free from restriction upon a Change in Control. If no such termination or resignation occurs
during the Covered Period and the outstanding restricted stock or deferred stock unit awards are substituted or assumed, your restricted
stock and deferred stock unit awards shall continue to vest in accordance with the terms of the Company&rsquo;s equity incentive plans
or applicable award agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">5.</TD><TD><U>Successors; Binding Agreement</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Assumption
By Successor</U>. The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise)
to all or substantially all of the business or assets of the Company to expressly assume and agree to perform this Agreement in the same
manner and to the same extent that the Company would be required to perform it if no such succession had taken place. Failure of the
Company to obtain such assumption and agreement prior to the effectiveness of any such succession shall be a breach of this Agreement
and shall entitle you to compensation from the Company in the same amount and on the same terms as you would be entitled hereunder if
you had terminated your employment for Good Reason following a Change in Control, except that for purposes of implementing the foregoing,
the date on which any such succession becomes effective shall be deemed the Date of Termination. As used in this Agreement, &ldquo;<I>the
Company</I>&rdquo; shall mean the Company as hereinbefore defined and any successor to its business or assets which assumes and agrees
to perform this Agreement by operation of law, by agreement or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Enforceability
By Beneficiaries</U>. This Agreement shall inure to the benefit of and be enforceable by your personal or legal representatives, executors,
administrators, successors, heirs, distributees, devisees and legatees. If you should die while any amount would still be payable to
you hereunder if you had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the
terms of this Agreement to your devisee, legatee or other designee or, if there is no such designee, to your estate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Nonsolicitation;
Confidentiality</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Nonsolicitation</U>.
For two years following your Date of Termination, you shall not, without the prior written consent of the Company, directly or indirectly,
as a sole proprietor, member of a partnership, stockholder or investor, officer or director of a corporation, or as an employee, associate,
consultant, independent contractor or agent of any person, partnership, corporation or other business organization or entity other than
the Company: (i)&nbsp;solicit or endeavor to entice away from the Company or any of its affiliates or subsidiaries, any person or entity
who is, or, during the then most recent 12-month period, was, employed by, or had served as an agent or key consultant of, the Company
or any of its subsidiaries, or (ii)&nbsp;solicit or endeavor to entice away from the Company or any of its subsidiaries any person or
entity who is, or was within the then most recent 12-month period, a customer or client (or reasonably anticipated (to your general knowledge
or the public&rsquo;s general knowledge) to become a customer or client) of the Company or any of its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Confidentiality</U>.
On and after the date of this Agreement, you will not, except in the performance of your obligations to the Company hereunder or as may
otherwise be approved in advance by the Board, directly or indirectly, disclose or use (except for the direct benefit of the Company)
any confidential information that you may learn or have learned by reason of your association with the Company, any customer or client
of the Company or any of their respective subsidiaries and affiliates. The term &ldquo;<I>confidential information</I>&rdquo; includes
all data, analyses, reports, interpretations, forecasts, documents and information in any form concerning or otherwise reflecting information
and concerning the Company and its affairs, including, without limitation, with respect to clients, products, policies, procedures, methodologies,
trade secrets and other intellectual property, systems, personnel, confidential reports, technical information, financial information,
business transactions, business plans, prospects or opportunities, but shall exclude any portion of such information that (i)&nbsp;was
acquired by you prior to your employment by, or other association with, the Company or any affiliated or predecessor entity, (ii)&nbsp;is
or becomes generally available to the public or is generally known in the industry or industries in which the Company or any customer
or client of the Company operates, in each case other than as a result of disclosure by you in violation of this Section&nbsp;6 or (iii)&nbsp;you
are required to disclose under any applicable laws, regulations or directives of any government agency, tribunal or authority having
jurisdiction in the matter or under subpoena or other process of law. As used in this Section&nbsp;6, an &ldquo;<I>affiliate</I>&rdquo;
of a person or entity is a person or entity in control of, controlled by, or in common control with, such first person or entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Definitions</U>.
For purposes of this Agreement, the following capitalized words shall have the meanings set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<I>Accounting Firm</I>&rdquo; shall mean
the then-current independent registered public accounting firm of the Company or, if such firm is unable or unwilling to perform such
calculations, such other national registered public accounting firm as shall be designated by agreement between you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<I>Cause</I>&rdquo; shall mean the willful
engaging by you in criminal or fraudulent acts or gross misconduct that is demonstrably and materially injurious to the Company, monetarily
or otherwise. No act or failure to act on your part shall be deemed &ldquo;<I>willful</I>&rdquo; unless done, or omitted to be done,
by you not in good faith and without reasonable belief that your action or omission was in the best interest of the Company. Notwithstanding
the foregoing, you shall not be deemed to have been terminated for Cause unless and until there shall have been delivered to you a copy
of a resolution duly adopted by the affirmative vote of not less than three quarters of the entire membership of the Board at a meeting
of the Board called and held for such purpose (after reasonable notice to you and an opportunity for you, together with your counsel,
to be heard before the Board), finding that in the good faith opinion of the Board you were guilty of conduct set forth above in the
first sentence of this subsection and specifying the particulars thereof in detail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<I>Change in Control</I>&rdquo; shall mean
the happening of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
acquisition, other than from the Company, by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3)&nbsp;or 14(d)(2)&nbsp;of
the Securities Exchange Act of 1934, as amended (the &ldquo;<I>Exchange Act</I>&rdquo;)) of beneficial ownership (within the meaning
of Rule&nbsp;13d-3 promulgated under the Exchange Act) of 20% or more of either (i)&nbsp;the then outstanding shares of common stock
of the Company (the &ldquo;<I>Outstanding Company Common Stock</I>&rdquo;) or (ii)&nbsp;the combined voting power of the then outstanding
voting securities of the Company entitled to vote generally in the election of directors (the &ldquo;<I>Company Voting Securities</I>&rdquo;);
<I>provided</I>, <I>however</I>, that any acquisition by (x)&nbsp;any non-corporate shareholder of the Company who owned 10% or more
of the Outstanding Company Common Stock as of the effective date of the initial registration of an offering of Stock under the Securities
Act of 1933, (y)&nbsp;the Company or any of its affiliates or subsidiaries, or any employee benefit plan (or related trust) sponsored
or maintained by the Company or any of its subsidiaries or (z)&nbsp;any corporation with respect to which, following such acquisition,
more than 50% of, respectively, the then outstanding shares of common stock of such corporation and combined voting power of the then
outstanding voting securities of such corporation entitled to vote generally in the election of directors is then beneficially owned,
directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of
the Outstanding Company Common Stock and Company Voting Securities immediately prior to such acquisition in substantially the same proportion
as their ownership, immediately prior to such acquisition, of the Outstanding Common Stock and Company Voting Securities, as the case
may be, shall not constitute a Change in Control of the Company; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Individuals
who, as of the Effective Date, constitute the Board (the &ldquo;<I>Incumbent Board</I>&rdquo;) cease for any reason to constitute at
least a majority of the Board, provided that any individual becoming a director subsequent to such effective date whose election or nomination
for election by the Company&rsquo;s shareholders, was approved by a vote of at least a majority of the directors then comprising the
Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose,
any such individual whose initial assumption of office is in connection with an actual or threatened election contest relating to the
election of the Directors of the Company (as such terms are used in Rule&nbsp;14a-11 of Regulation 14A promulgated under the Exchange
Act); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Consummation
of a reorganization, merger, consolidation or similar transaction involving the Company (a &ldquo;<I>Business Combination</I>&rdquo;),
in each case, with respect to which all or substantially all of the individuals and entities who were the respective beneficial owners
of the Outstanding Company Common Stock and Company Voting Securities immediately prior to such Business Combination do not own beneficially,
directly or indirectly, more than 50% of, respectively, the then outstanding shares of common stock and the combined voting power of
the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation
resulting from such Business Combination in substantially the same proportion as their ownership immediately prior to such Business Combination
of the Outstanding Company Common Stock and Company Voting Securities, as the case may be; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">A
complete liquidation or dissolution of the Company or a sale or other disposition of all or substantially all of the assets of the Company
other than to a corporation with respect to which, following such sale or disposition, more than 50% of, respectively, the then outstanding
shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election
of directions is then owned beneficially, directly or indirectly, by all or substantially all of the individuals and entities who were
the beneficial owners, respectively, of the Outstanding Company Common Stock and Company Voting Securities immediately prior to such
sale or disposition in substantially the same proportion as their ownership of the Outstanding Company Common Stock and Company Voting
Securities, as the case may be, immediately prior to such sale or disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Notwithstanding the foregoing, with respect to any amounts
payable under this Agreement that are subject to Section&nbsp;409A of the Code where the payment is to be accelerated in connection with
the Change in Control, no event(s)&nbsp;set forth above shall constitute a Change in Control for purposes of the Agreement unless such
event(s)&nbsp;also constitutes a &ldquo;change in the ownership&rdquo;, &ldquo;change in the effective control&rdquo; or a &ldquo;change
in the ownership of a substantial portion of the assets&rdquo; of the Company as defined under Section&nbsp;409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<I>Code</I>&rdquo; shall mean the Internal
Revenue Code of 1986, as amended, and any successor provisions thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<I>Date of Termination</I>&rdquo; shall be
the date on which you experience a &ldquo;separation from service&rdquo; (as defined in Section&nbsp;1.409A-1(h)&nbsp;of the Treasury
Regulations) from the Company upon the termination of your employment by the Company without Cause or by you for Good Reason. Such Date
of Termination shall be the date specified in the Notice of Termination (which, in the case of a termination by the Company without Cause
shall not be less than 30 days, and in the case of a resignation by you for Good Reason shall not be less than 30 nor more than 60 days
from the date such Notice of Termination is given); <I>provided</I>, that if within 30 days after any Notice of Termination is given
the party receiving such Notice of Termination notifies the other party that a dispute exists concerning the termination, the Date of
Termination shall be the date on which the dispute is finally determined, either by mutual written agreement of the parties, by a binding
arbitration award, or by a final judgment, order or decree of a court of competent jurisdiction (which is not appealable or the time
for appeal therefrom having expired and no appeal having been perfected); <I>provided, further,</I> that the Date of Termination shall
be extended by a notice of dispute only if such notice is given in good faith and the party giving such notice pursues the resolution
of such dispute with reasonable diligence. Notwithstanding the pendency of any such dispute, the Company will continue to pay you your
full compensation in effect when the notice giving rise to the dispute was given, continue you as a participant in all compensation,
benefit, and insurance plans and perquisites in which you were participating when the notice giving rise to the dispute was given and
the Company will not require that you provide any services to the Company, until the dispute is finally resolved in accordance with this
Subsection. Amounts paid under this Subsection are in addition to all other amounts due under this Agreement and shall not be offset
against or reduce any other amounts due under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<I>Good Reason</I>&rdquo; shall mean, without
your express written consent, any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
assignment to you of any duties inconsistent with your status as an executive officer of the Company or an adverse alteration in the
nature or status of your duties, responsibilities, authorities, reporting relationships or titles from those in effect immediately prior
to the Change in Control;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">A
reduction by the Company in your annual base salary as in effect on the date hereof or as the same may be increased from time to time;
a failure by the Company to increase your salary at a rate commensurate with that of other key executives of the Company; a reduction
in your annual bonus (expressed as a percentage of base salary) below the target in effect for you immediately prior to the Change in
Control; or any adverse change in your long-term incentive opportunities in comparison to those in effect prior to the Change in Control;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
relocation of your principal place of work to any location (other than the Company&rsquo;s main headquarters) that is more than 50 miles
from your principal place of work on the date of the Change in Control (except for required travel on the Company&rsquo;s business to
an extent substantially consistent with your customary business travel obligations in the ordinary course of business prior to the Change
in Control), or in the event you consent to any such relocation, the Company&rsquo;s failure to provide you with all of the benefits
of the Company&rsquo;s relocation policy as in operation immediately prior to the Change in Control;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
failure by the Company to continue in effect any compensation plan, including, but not limited to, incentive or deferred compensation
plans, in which you participate or the failure by the Company to continue your participation therein on at least as favorable a basis,
both in terms of the amount of benefits provided and the level of your participation relative to other participants, as existed at the
time of the Change in Control;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
failure by the Company to continue to provide you with benefits at least as favorable as those enjoyed by you under any of the Company&rsquo;s
retirement, life insurance, medical, health and accident, disability or savings plans in which you were participating at the time of
the Change in Control; the taking of any action by the Company that would directly or indirectly reduce any of such benefits or deprive
you of any perquisite enjoyed by you at the time of the Change in Control including without limitation, the use of a car, secretary,
office space, telephones, expense reimbursement and club dues; or the failure by the Company to provide you with the number of paid vacation
days to which you are entitled on the basis of years of service with the Company in accordance with the Company&rsquo;s normal vacation
policy in effect at the time of the Change in Control;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
failure of the Company to pay you any amounts of salary, bonus, benefits or expense reimbursement then owed to you or the failure of
the Company to adhere to its payroll and other compensation schedules in place just prior to the Change in Control, including, but not
limited to, the failure to pay any installment of deferred compensation under any deferred compensation plan or program of the Company,
within seven (7)&nbsp;days of the date the compensation is due;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(g)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
failure of the Company to obtain a satisfactory agreement from any successor to assume and agree to perform this Agreement, as contemplated
in Section&nbsp;5 hereof or, if the business of the Company for which your services are principally performed is sold at any time after
a Change in Control, the purchaser of such business shall fail to agree to provide you with the same or a comparable position, duties,
compensation and benefits (as described in subsections (d)&nbsp;and (e)&nbsp;above) as provided to you by the Company immediately prior
to the Change in Control; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(h)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Any
purported termination of your employment which is not effected pursuant to a Notice of Termination satisfying the requirements of Section&nbsp;2
(and, if applicable, the requirements set out in the definition of &ldquo;<I>Cause</I>&rdquo; above); for purposes of this Agreement,
no such purported termination shall be effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Your right to terminate your employment for Good
Reason will not be affected by your incapacity due to physical or mental illness. Your continued employment will not constitute a waiver
of rights with respect to any act or failure to act that constitutes Good Reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<I>Payment</I>&rdquo; means (i)&nbsp;any
amount due or paid to you under this Agreement, (ii)&nbsp;any amount that is due or paid to you under any plan, program or arrangement
of the Company and its subsidiaries, and (iii)&nbsp;any amount or benefit that is due or payable to you under this Agreement or under
any plan, program or arrangement of the Company and its subsidiaries not otherwise covered under clause (i)&nbsp;or (ii)&nbsp;hereof
which must reasonably be taken into account under Section&nbsp;280G of the Code and the Regulations in determining the amount of the
 &ldquo;<I>parachute payments</I>&rdquo; received by you, including, without limitation, any amounts which must be taken into account
under the Code and Regulations as a result of (x)&nbsp;the acceleration of the vesting of Options, restricted stock or other equity awards,
(y)&nbsp;the acceleration of the time at which any payment or benefit is receivable by you or (z)&nbsp;any contingent severance or other
amounts that are payable to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<I>Regulations</I>&rdquo; shall mean the
proposed, temporary and final regulations under Section&nbsp;280G of the Code or any successor provision thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<I>Taxes</I>&rdquo; shall mean the federal,
state and local income taxes to which you are subject at the time of determination, calculated on the basis of the highest marginal rates
then in effect, plus any additional payroll or withholding taxes to which you are then subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">8.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notice</U>.
For the purpose of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be
deemed to have been duly given when delivered or mailed by United States registered mail, return receipt requested, postage prepaid,
addressed to, the Chief Executive Officer or the General Counsel, Boston Scientific Corporation, 300 Boston Scientific Way, Marlborough,
MA 01752-1234, or to you at the address set forth on the first page&nbsp;of this Agreement or to such other address as either party may
have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>.
No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing.
No waiver by either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision
of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the
same or at any prior or subsequent time. No agreements or representations, oral or otherwise, express or implied, with respect to the
subject matter hereof have been made by either party that are not expressly set forth in this Agreement and this Agreement shall supersede
all prior agreements, negotiations, correspondence, undertakings and communications of the parties, oral or written, with respect to
the subject matter hereof. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws
of the Commonwealth of Massachusetts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Validity</U>.
The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision
of this Agreement, which shall remain in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Counterparts</U>.
This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together will
constitute one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">12.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Arbitration</U>.
Any dispute or controversy arising under or in connection with this Agreement shall be settled exclusively by arbitration in Boston in
accordance with the rules&nbsp;of the American Arbitration Association then in effect. Judgment may be entered on the arbitrator&rsquo;s
award in any court having jurisdiction; <I>provided, however</I>, that you shall be entitled to seek specific performance of your right
to be paid until the Date of Termination during the pendency of any dispute or controversy arising under or in connection with this Agreement.
You shall be entitled to legal fees and expenses relating to an arbitration in accordance with the terms of Section&nbsp;3(a)(iii)&nbsp;of
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">13.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Contract of Employment</U>. Nothing in this Agreement shall be construed as giving you any right to be retained in the employ of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">14.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Headings</U>.
The headings contained in this Agreement are intended solely for convenience and shall not affect the rights of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If this letter sets forth our agreement on the subject matter hereof,
kindly sign and return to the Company the enclosed copy of this letter which will then constitute our agreement on this subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Sincerely,</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 46%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; width: 49%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">BOSTON SCIENTIFIC
    CORPORATION</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">[INSERT NAME]</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Date&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Chair and CEO</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">The foregoing is
    accepted and agreed to.</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">[INSERT NAME]</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;Date</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RELEASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I am a party to an agreement with Boston Scientific Corporation (the
 &ldquo;Company&rdquo;), dated [Insert Date] entitled Change in Control Agreement (the &ldquo;Change in Control Agreement&rdquo;). I acknowledge
that this is the Release Agreement required by the Company pursuant to Section&nbsp;3(a)(i)(2)&nbsp;of the Change in Control Agreement
as a condition of my eligibility for the Severance Payment (as defined in the Change in Control Agreement) (the &ldquo;Consideration&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">1.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Release
of Claims. In consideration of and in exchange for the commitment of the Company to provide the Consideration,&nbsp;I, for myself, my
heirs, administrators, executors and assigns agree to release and forever discharge the Company and its subsidiaries, affiliated companies,
successors and assigns, and the current and former employees, officers, directors, shareholders (but only in their capacity as shareholders
of the Company) and agents of each of the foregoing (the &ldquo;Released Parties&rdquo;), from any and all claims, agreements, obligations,
injuries, damages, causes of action, debts or liabilities (together &ldquo;Claims&rdquo;), including, without limitation, Claims under
the Civil Rights Act of 1866, Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act of 1967 (&ldquo;ADEA&rdquo;),
the Civil Rights Act of 1991, the Americans with Disabilities Act of 1990, the Family and Medical Leave Act of 1993, and any other federal,
state, local or foreign law, that I may have, may have ever had or may possess in the future, whether known or unknown, against any of
the Released Parties, arising out of (i)&nbsp;my employent relationship with and service as an employee, officer or director of the Company,
and the termination of such relationship or service, and (ii)&nbsp;any event, condition, circumstance or obligation that occurred, existed
or arose on or prior to the date hereof; <I>provided</I>, <I>however</I>, that I do not release, discharge, or waive any rights to payments
and benefits under the Change in Control Agreement that are contingent upon my execution of this Release Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">2.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Consideration
of Release Agreement. I understand that I have had the opportunity, in accordance with ADEA, if I so desired, to take up to twenty-one
(21) days to consider this Release Agreement. I agree that any modifications, material or otherwise, made to this Release Agreement do
not restart or affect in any manner the original twenty-one (21) day consideration period. I further acknowledge that I have been advised
to consult with an attorney prior to executing this Release Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">3.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Revocation
Period. I understand that, in accordance with ADEA,&nbsp;I will have seven (7)&nbsp;days following my signing of this Release Agreement
in which to revoke this Release Agreement by a written notice to be received by the Company&rsquo;s Senior Vice President, Secretary
and General Counsel no later than the end of such seven-day period. I understand that this Release Agreement shall not become effective
until the revocation period has expired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">4.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Receipt
of Payment. I acknowledge that I have received payment for all salary, vacation pay and other compensation due to me based on my employment
with the Company to and including the most recent regular payroll date of the Company preceding the date of my signing the Release Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">5.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">No
Admission. I understand and agree that this Release Agreement is not to be construed as an admission of liability by the Released Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">6.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Miscellaneous
Provisions. I agree that this Release Agreement shall be subject to Sections 8, 9, 10, 11, 12 and 14 of the Change in Control Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">7.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Full
Review of Release Agreement. My signature below confirms that I have carefully read and reviewed this Release Agreement. I fully understand
all of its terms and conditions and have not relied upon any other representation by the Company or the employees or agents of the Company
concerning the terms of this Release Agreement. I execute and deliver this Release Agreement freely and voluntarily.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">UNDERSTOOD, ACCEPTED AND AGREED</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">[INSERT NAME]</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Date:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm2214421d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BOSTON SCIENTIFIC CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYEE STOCK PURCHASE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amended and Restated Effective as of July&nbsp;1,
2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Purpose.</U>
The purpose of the Boston Scientific Corporation Employee Stock Purchase Plan, as amended and renamed (formerly known as the Boston Scientific
Corporation 2006 Global Employee Stock Ownership Plan), is to encourage ownership of common stock by employees of Boston Scientific Corporation
and its Subsidiaries and Affiliates and to provide additional incentives for such employees to promote the success of the business of
the Company and its Subsidiaries and Affiliates. The Company intends for offerings under the Plan to qualify as an &ldquo;employee stock
purchase plan&rdquo; under Section&nbsp;423 of the Code (each, a &ldquo;Section&nbsp;423 Offering&rdquo;); provided, however, that the
Committee may also authorize the grant of rights under offerings of the Plan that are not intended to comply with the requirements of
Section&nbsp;423 of the Code, pursuant to any rules, procedures, agreements, appendices, or sub-plans adopted by the Committee for such
purpose (each, a &ldquo;Non-423 Offering&rdquo;). Unless otherwise determined by the Committee, each offering under the Plan in which
Eligible Employees of one or more Participating Employers may participate shall be deemed a separate offering for purposes of Section&nbsp;423
of the Code, even if the dates of the applicable Offering Periods of each such offering are identical, and the provisions of the Plan
shall separately apply to each offering. With respect to Section&nbsp;423 Offerings, the terms of separate offerings need not be identical
provided that all Eligible Employees granted Options in a particular offering shall have the same rights and privileges, except as otherwise
may be permitted by Section&nbsp;423 of the Code; a Non-423 Offering need not satisfy such requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Effective
Date of the Plan.</U> The Plan&rsquo;s original effective date was July&nbsp;1, 2006 following the Board&rsquo;s adoption of the Plan
on February&nbsp;28, 2006 and approval by the Company&rsquo;s stockholders on May&nbsp;9, 2006. The Plan was amended and restated effective
as of July&nbsp;1, 2011, as of July&nbsp;1, 2014 and as of November&nbsp;15, 2018 and is hereby further amended and restated effective
as of July&nbsp;1, 2022; provided, however, such amendment and restatement shall be void if the Company&rsquo;s stockholders do not approve
the amended and restated Plan within twelve (12) months before or after the date on which the Board adopts the amended and restated Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Administration.</U></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
Plan shall be administered by the Committee. Subject to Applicable Law, no member of the Board or Committee (or its delegates) will be
liable for any good faith action or determination made in connection with the operation, administration or interpretation of the Plan.
In the performance of its responsibilities with respect to the Plan, the Committee will be entitled to rely upon, and no member of the
Committee will be liable for any action taken or not taken in reliance upon, information and/or advice furnished by the Company&rsquo;s
officers or employees, the Company&rsquo;s accountants, the Company&rsquo;s counsel and any other party that the Committee deems necessary.
Notwithstanding any other provision of the Plan to the contrary, the Committee may use telephonic media, electronic media, or other technology,
including the Company&rsquo;s website and the internet, in administering the Plan to the extent not prohibited by Applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Powers
of the Committee</U>. The Committee will have full power and authority to administer the Plan, including, without limitation, the authority
to (i)&nbsp;construe, interpret, reconcile any inconsistency in, correct any default in and supply any omission in, and apply the terms
of the Plan and any enrollment form or other instrument or agreement relating to the Plan, (ii)&nbsp;determine eligibility and adjudicate
all disputed claims filed under the Plan, including whether Eligible Employees will participate in a Section&nbsp;423 Offering or a Non-423
Offering and which Subsidiaries and Affiliates will be Participating Employers participating in either a Section&nbsp;423 Offering or
a Non-423 Offering (within the limits of the Plan), (iii)&nbsp;determine the terms and conditions of any Option granted under the Plan,
(iv)&nbsp;establish, amend, suspend or waive such rules&nbsp;and regulations and appoint such agents as it deems appropriate for the proper
administration of the Plan, (v)&nbsp;amend an outstanding Option, including any amendments to an Option that may be necessary for purposes
of effecting a transaction contemplated under Section&nbsp;11 hereof (including, but not limited to, an amendment to the class or type
of stock that may be issued pursuant to the exercise of a right or the purchase price applicable to an Option), provided that the amended
Option otherwise conforms to the terms of the Plan, and (vi)&nbsp;make any other determination and take any other action that the Committee
deems necessary or desirable for the administration of the Plan, including, without limitation, the adoption of any such rules, procedures,
agreements, appendices, or sub-plans (collectively, &ldquo;Sub-Plans&rdquo;) as are necessary or appropriate to permit the participation
in the Plan by Eligible Employees who are foreign nationals or employed outside the U.S., as further set forth in Section&nbsp;3(c)&nbsp;below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Non-U.S.
Sub-Plans</U>. Notwithstanding any provision to the contrary in this Plan, the Committee may adopt such Sub-Plans relating to the operation
and administration of the Plan to accommodate local laws, customs and procedures for jurisdictions outside of the U.S., the terms of which
Sub-Plans may take precedence over other provisions of this Plan, with the exception of Section&nbsp;5 hereof, but unless otherwise superseded
by the terms of such Sub-Plan, the provisions of this Plan will govern the operation of such Sub-Plan. To the extent inconsistent with
the requirements of Section&nbsp;423 of the Code, any such Sub-Plan will be considered part of a Non-423 Offering, and Options granted
thereunder will not be required by the terms of the Plan to comply with Section&nbsp;423 of the Code. Without limiting the generality
of the foregoing, the Committee is authorized to adopt Sub-Plans for particular non-U.S. jurisdictions that modify the terms of the Plan
to meet applicable local requirements, customs or procedures regarding, without limitation, (i)&nbsp;eligibility to participate, (ii)&nbsp;the
definition of Compensation, (iii)&nbsp;the dates and duration of Offering Periods or other periods during which Optionees may make payroll
deductions towards the purchase of shares of Stock, (iv)&nbsp;the method of determining the purchase price and the discount from Fair
Market Value at which shares of Stock may be purchased, (v)&nbsp;any minimum or maximum amount of payroll deductions an Optionee may make
in an Offering Period or other specified period under the applicable Sub-Plan, (vi)&nbsp;the treatment of Options upon a change in control
or a change in capitalization of the Company, (vii)&nbsp;the handling of payroll deductions and the methods for making payroll deductions
by means other than payroll deductions, (viii)&nbsp;establishment of bank, building society or trust accounts to hold payroll deductions,
(ix)&nbsp;payment of interest, (x)&nbsp;conversion of local currency, (xi)&nbsp;obligations to pay payroll tax, (xii)&nbsp;withholding
procedures, and (xiii)&nbsp;handling of share issuances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Binding
Authority</U>. All determinations by the Committee in carrying out and administering the Plan and in construing and interpreting the Plan
and any enrollment form or other instrument or agreement relating to the Plan will be made in the Committee&rsquo;s sole discretion and
will be final, binding and conclusive for all purposes and upon all interested persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Delegation
of Authority</U>. To the extent not prohibited by Applicable Law, the Committee may, from time to time, delegate some or all of its authority
under the Plan to a subcommittee or subcommittees of the Committee, to one or more of the other parties comprising the &ldquo;Committee&rdquo;
hereunder, or to other persons or groups of persons as it deems necessary, appropriate or advisable under conditions or limitations that
it may set at or after the time of the delegation. For purposes of the Plan, reference to the Committee will be deemed to include any
subcommittee, subcommittees, or other persons or groups of persons to whom the Committee delegates authority pursuant to this Section&nbsp;3(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Amendment
and Termination.</U> The Board may terminate or amend the Plan at any time and from time to time; <FONT STYLE="background-color: white">provided
that, if stockholder approval is required pursuant to Applicable Law, then no such amendment will be effective unless approved by the
Company&rsquo;s stockholders within such time period as may be required. The Board may suspend the Plan or discontinue the Plan at any
time, including shortening an Offering Period in connection with a spin-off or other similar corporate event. Upon termination of the
Plan, all payroll deductions will cease and all payroll deductions then credited to an Optionee&rsquo;s account will be equitably applied
to</FONT> the purchase of whole shares of Stock then available for sale, and any remaining amounts will be promptly refunded, without
interest (unless required by Applicable Law), to Optionees. For the avoidance of doubt, the Board or Committee, as applicable herein,
may not delegate its authority to make amendments to or suspend the operations of the Plan pursuant to this Section&nbsp;4. No termination
of or amendment of the Plan may adversely affect the rights of an Optionee in the reasonable discretion of the Committee with respect
to any Option held by the Optionee as of the date of such termination or amendment without the Optionee&rsquo;s consent, provided that
no such consent shall be required for any amendment or termination of the Plan that may be required to facilitate compliance with Applicable
Law in the reasonable discretion of the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Shares
of Stock Subject to the Plan.</U> No more than an aggregate of 60 million shares of Stock may be issued or delivered pursuant to the exercise
of Options granted under the Plan. Shares to be delivered upon the exercise of Options may be either shares of Stock which are authorized
but unissued or shares of Stock held by the Company in its treasury or shares of Stock purchased on the open market by the Company for
issuance under this Plan. If an Option expires or terminates for any reason without having been exercised in full, the unpurchased shares
subject to the Option shall become available for other Options granted under the Plan. The Company shall, at all times during which Options
are outstanding, reserve and keep available shares of Stock sufficient to satisfy such Options, and shall pay all fees and expenses incurred
by the Company in connection therewith. In the event of any capital change in the outstanding Stock as contemplated by Section&nbsp;11,
the number and kind of shares of Stock or securities reserved and kept available by the Company shall be appropriately adjusted. For avoidance
of doubt, up to the maximum number of Shares reserved under this Section&nbsp;5 may be used to satisfy purchases of shares of Stock under
Section&nbsp;423 Offerings and any remaining portion of such maximum number of shares of Stock may be used to satisfy purchases of shares
of Stock under Non-423 Offerings. Further, shares of Stock withheld to satisfy Tax-Related Items shall not reduce the number of shares
of Stock available for sale pursuant to the Plan and shall again be made available for sale pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Terms
and Conditions of Options.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>General;
Offering Periods.</U> All Options granted to Eligible Employees shall comply with the terms and conditions set forth in the Plan and applicable
Enrollment Agreement. The Committee has the authority to change the rules&nbsp;set forth in this Section&nbsp;6 regarding participation
in the Plan. Unless otherwise determined by the Committee, the Plan shall be implemented by consecutive Offering Periods. To the extent
determined by the Committee, the Offering Periods may (a)&nbsp;consist of more than one purchase period of a duration specified by the
Committee, and (b)&nbsp;be of a duration, and commence on the dates, specified by the Committee prior to the scheduled beginning of the
applicable Offering Period, provided that each Offering Period may not have a duration exceeding twenty-seven (27) months. For the avoidance
of any doubt, the Committee has authority to establish the terms that shall apply to the Offering Periods in accordance with the provisions
contemplated in this Section&nbsp;6 without stockholder approval. To the extent that the Committee establishes Offering Periods with multiple
purchase periods or overlapping Offering Periods, in each case, with a purchase price based (in part) on the Fair Market Value of a share
of Stock on the first Trading Day of an Offering Period, the Committee shall have discretion to structure an Offering Period so that if
the Fair Market Value of a share of Stock on the first Trading Day of the Offering Period in which Optionee is currently enrolled is higher
than the Fair Market Value of a share of Stock on the first Trading Day of any subsequent Offering Period, the Company shall automatically
enroll such Optionee in the subsequent Offering Period and shall terminate his or her participation in such original Offering Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Non-U.S.
Employees</U>. An Eligible Employee who works for a Participating Employer and is a citizen or resident of a jurisdiction other than the
U.S. (without regard to whether such individual also is a citizen or resident of the U.S. or is a resident alien (within the meaning of
Section&nbsp;7701(b)(1)(A)&nbsp;of the Code)) may be excluded from participation in the Plan or an Offering Period if the participation
of such Eligible Employee is prohibited under the laws of the applicable jurisdiction or if complying with the laws of the applicable
jurisdiction would cause the Plan or a Section&nbsp;423 Offering to violate Section&nbsp;423 of the Code. In the case of a Non-423 Offering,
an Eligible Employee (or group of Eligible Employees) may be excluded from participation in the Plan or an Offering Period if the Committee
has determined, in its sole discretion, that participation of such Eligible Employee(s)&nbsp;is not advisable or practicable for any reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Enrollment
Agreement/Payroll Deductions.</U> During each Enrollment Period, an Eligible Employee may elect to participate in the Plan as of the Entry
Date and purchase shares of Stock by completing and submitting an Enrollment Agreement, in accordance with such procedures as may be established
from time to time by the Committee in its sole discretion. The Enrollment Agreement shall indicate the percentage of the Eligible Employee&rsquo;s
Compensation (from 1% through 10% (or such lesser or greater percentage determined by the Committee in connection with a particular Offering
Period), in multiples of 1%) that the Eligible Employee elects to be withheld on pay dates occurring during the Offering Period. The Compensation
shall be withheld in the form of payroll deductions made on each pay day during the Offering Period, provided that if the Committee determines
that payroll deductions are not permitted or feasible in a particular country outside of the U.S., the Committee may permit an Eligible
Employee to participate by an alternative means (in which case any reference to payroll deductions in this Plan shall also mean the contributions
made through other means).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">After
the commencement of the Offering Period, unless the Committee determined otherwise in connection with a particular Offering Period, an
Optionee shall not be permitted to change the percentage of Compensation elected to be withheld during that Offering Period. However,
an Optionee may elect to discontinue his or her payroll deductions at any time during an Offering Period and withdraw them by submitting
a request, in accordance with such procedures as may be established from time to time by the Committee, no later than ten (10)&nbsp;business
days prior (or such other period as may be established by the Committee) to the last day of the Offering Period. The change will be effective
as of the first pay date occurring as soon as practicable after the Optionee&rsquo;s request has been received. As soon as practicable
following receipt of the Optionee&rsquo;s request, the Optionee shall receive a distribution of the accumulated payroll deductions, without
interest (unless otherwise required by Applicable Law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Any
Enrollment Agreement in effect for an Offering Period shall remain in effect as to any subsequent Offering Period unless revoked by the
submission of a request to discontinue payroll deductions for that Offering Period or modified by submission of a new Enrollment Agreement
during an Enrollment Period for any Offering Period (or such other period as may be established by the Committee), or until the Optionee
ceases to be an Eligible Employee for any reason. Participation in the subsequent Offering Period will be governed by the terms and conditions
of the Plan in effect at the beginning of such Offering Period, subject to the Optionee's right to withdraw from the Plan in accordance
with Section&nbsp;6(c)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
Company will not be obligated to segregate the payroll deductions from the general funds of any Participating Employer nor will any interest
be paid on such payroll deductions, unless otherwise determined by the Committee or required by Applicable Law. All payroll deductions
received by the Company for shares of Stock sold by the Company on any Purchase Date pursuant to this Plan may be used for any corporate
purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Limitations</U>.
Notwithstanding any provisions of the Plan to the contrary, no Eligible Employee shall be granted an Option under the Section&nbsp;423
Offering to the extent that, immediately after the grant, such Eligible Employee (or any other person whose stock would be attributed
to such Eligible Employee pursuant to Section&nbsp;424(d)&nbsp;of the Code) would own capital stock of the Company and/or hold outstanding
rights to purchase capital stock possessing five percent (5%) or more of the combined voting power or value of all classes of the capital
stock of the Company or of any Subsidiary of the Company, or (ii)&nbsp;to the extent that his or her rights to purchase capital stock
under all employee stock purchase plans of the Company and Subsidiaries accrues at a rate that exceeds Twenty-Five Thousand Dollars (USD&nbsp;25,000)
worth of such stock (determined at the fair market value of the shares of such stock at the time such right is granted) for each calendar
year in which such purchase right is outstanding. Subject to the limitations set forth in the foregoing sentence, no Optionee may purchase
in excess of 10,000 shares of Stock under the Plan per Offering Period or such other maximum number of shares of Stock as may be established
for an Offering Period by the Committee (in each case subject to adjustment pursuant to Section&nbsp;11 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Purchase
Price.</U> Unless determined otherwise by the Committee, the purchase price at which Option Shares may be acquired on the Purchase Date
shall be equal to eighty-five percent (85%) of the lesser of (i)&nbsp;the Fair Market Value of the Stock on the Offering Commencement
Date; and (ii)&nbsp;the Fair Market Value of the Stock on the Purchase Date; provided, however, that the Purchase Price for a Section&nbsp;423
Offering shall in no event be less than eighty-five percent (85%) of the lesser of (i)&nbsp;the Fair Market Value of the Stock on the
Offering Commencement Date; and (ii)&nbsp;the Fair Market Value of the Stock on the Purchase Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">7.</TD><TD STYLE="text-align: justify"><U>Exercise of Options.</U></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">For
each Optionee who remains an Eligible Employee on a Purchase Date, all of the Optionee&rsquo;s payroll deductions accumulated during the
Offering Period will be applied to purchase the number of whole shares of Stock (unless the Committee has determined in connection with
a particular Offering Period that fractional shares of Stock may be purchased) purchasable by his or her accumulated payroll deductions
during the Offering Period, or, if less, the maximum number of shares subject to the Option as provided in Section&nbsp;6(d), provided
that if the total number of shares of Stock which all Optionees elect to purchase, together with any shares already purchased under the
Plan, exceeds the total number of shares which may be purchased under the Plan pursuant to Section&nbsp;5, the number of shares which
each Optionee is permitted to purchase shall be decreased <U>pro rata</U> based on the Optionee&rsquo;s accumulated payroll deductions
in relation to all accumulated payroll deductions currently being withheld under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Unless
otherwise determined by the Committee, following the purchase of Stock on each Purchase Date, any remaining payroll deductions for each
Optionee shall be refunded to the Optionee, without interest (unless required by Applicable Law), as soon as administratively practicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">If
an Optionee ceases to be an Eligible Employee prior to the Purchase Date, the Optionee&rsquo;s payroll deductions shall be refunded to
the Optionee, without interest (unless required by Applicable Law), as soon as administratively practicable, and no shares of Stock shall
be purchased on behalf of the Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">8.</TD><TD STYLE="text-align: justify"><U>Delivery of Stock.</U></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">By
enrolling in the Plan, each Optionee will be deemed to have authorized the establishment of a brokerage account on his or her behalf at
a securities brokerage firm selected by the Committee. Alternatively, the Committee may provide for Plan share accounts for each Optionee
to be established by the Company or by an outside entity selected by the Committee which is not a brokerage firm. As soon as administratively
practicable after the Purchase Date, the Company shall deliver shares of Stock acquired by the Optionee to the Optionee&rsquo;s brokerage
or Plan share account where the shares of Stock will be held in street name for the benefit of the Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
Committee shall record each Optionee&rsquo;s shares of Stock acquired under the Plan in accordance with established electronic book entry
procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">An
Optionee will have no rights as a stockholder with respect to any Option Shares or any shares of Stock deliverable under this Plan unless
and until recorded in the books of the brokerage firm selected by the Committee or, as applicable, the Company, its transfer agent, or
such other outside entity which is not a brokerage firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><U>Restrictions on Transfer.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Options
may not be assigned, transferred, pledged or otherwise disposed of other than by will or the laws of descent and distribution. An Option
may not be exercised by anyone other than the Optionee during the lifetime of the Optionee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Except
as otherwise determined by the Committee, Stock acquired by exercise of an Option hereunder may not be assigned, transferred, pledged
or otherwise disposed of, except by will or under the laws of descent and distribution, until the date which is three (3)&nbsp;months
after the last day of the Offering Period as of which such shares were acquired (or the date of the death of the Optionee, if earlier),
but thereafter may be sold or otherwise transferred without restriction, subject to the Company's Stock Trading Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Except
as otherwise determined by the Committee, Stock acquired by exercise of an Option under the Section&nbsp;423 Offering and deposited with
a broker designated by the Committee for the benefit of the Optionee pursuant to Section&nbsp;8(a)&nbsp;may not be transferred to any
other brokerage account for a period of two (2)&nbsp;years following the first day of the Offering Period to which the Option Shares relate.
After such restriction period ends, the Optionee may freely transfer the Option Shares to any other brokerage account, without restriction,
at the Optionee&rsquo;s personal expense. The Company may also require that shares of Stock, without regard to whether acquired by exercise
of an Option under a Section&nbsp;423 Offering, be retained in a brokerage or Plan share account for such other designated period of time
as may be specified by the Committee, and/or may establish procedures to permit tracking of dispositions of shares of Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><U>Employment.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>General</U>.
If an Optionee ceases to be an Eligible Employee prior to a Purchase Date for any reason, his or her Option shall immediately expire,
and the Optionee&rsquo;s accumulated payroll deductions shall be returned, without interest (unless otherwise required under Applicable
Law), as soon as administratively practicable, to the Optionee or his or her estate, as the case may be, by the Participating Employer,
and no shares of Stock shall be purchased on behalf of such Optionee. For the avoidance of doubt, if an Optionee&rsquo;s last day of employment
with a Participating Employer is on a Purchase Date, the Optionee&rsquo;s payroll deductions accumulated during the Offering Period will
be applied to purchase Stock on the Purchase Date pursuant to Section&nbsp;7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Leave
of Absence</U>. For purposes of a Section&nbsp;423 Offering under the Plan, an Employee shall not be deemed to have ceased to be an Eligible
Employee while such Employee is on any military leave, sick leave, or other bona fide leave of absence approved by the Participating Employer
of three (3)&nbsp;months or less; provided that where the period of leave exceeds three (3)&nbsp;months and the Optionee&rsquo;s right
to reemployment is not guaranteed by statute or by contract, for purposes of the Plan, the Employee will be deemed to have ceased to be
an Eligible Employee three (3)&nbsp;months and one (1)&nbsp;day following the commencement of such leave. Subject to the discretion of
the Committee, if an Optionee is granted a paid leave of absence, payroll deductions on behalf of the Optionee will continue and any payroll
deductions credited to the Optionee&rsquo;s account may be used to purchase shares of Stock as provided under the Plan. If an Optionee
is granted an unpaid leave of absence, payroll deductions on behalf of the Optionee will be discontinued and no other payroll deductions
will be permitted (unless otherwise determined by the Committee or required by Applicable Law), but any payroll deductions then credited
to the Optionee&rsquo;s account may be used to purchase shares of Stock on the next applicable Purchase Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Transfer
of Employment</U>. Unless otherwise determined by the Committee or required by Applicable Law, an Optionee whose employment transfers
or whose employment terminates with an immediate rehire (with no break in service) by or between a Participating Employer will not be
treated as having terminated employment for purposes of participating in the Plan or an Offering; however, if an Optionee transfers from
a Section&nbsp;423 Offering to a Non-423 Offering, the exercise of the Optionee&rsquo;s purchase right will be qualified under the Section&nbsp;423
Offering only to the extent that such exercise complies with Section&nbsp;423 of the Code. If an Optionee transfers from a Non-423 Offering
to a Section&nbsp;423 Offering, the exercise of the Optionee&rsquo;s purchase right will remained non-qualified under the Non-423 Offering.
The Committee may establish additional or different rules&nbsp;to govern transfers of employment for purposes of participation in the
Plan or an Offering, consistent with the applicable requirements of Section&nbsp;423 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">11.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Adjustment Provisions.</U></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Changes
in Capitalization</U>. In the event of (1)&nbsp;any dividend (other than regular cash dividends) or other distribution (whether in the
form of cash, Stock, other securities or other property), stock split, reverse stock split, reorganization, merger, consolidation, split-up,
split-off, spin-off, combination, repurchase or exchange of shares of Stock or other securities of the Company, recapitalization, or other
similar corporate transaction or event or change in the Company's capital structure that affects the shares of Stock (including a Change
in Control); or (2)&nbsp;unusual or nonrecurring events affecting the Company, including changes in Applicable Laws, that the Committee
determines, in its sole discretion, could result in substantial dilution or enlargement of the Options intended to be granted to, or available
for, Optionees (any event in (1)&nbsp;or (2), an &ldquo;Adjustment Event&rdquo;), the Committee will make such appropriate substitution
or adjustments, if any, as deems equitable, to any or all of (A)&nbsp;the maximum number of shares of Stock or kind of other securities
that may be delivered under the Plan under Section&nbsp;5 or any Sub-Plan and (B)&nbsp;the terms of any outstanding Options, including
(i)&nbsp;the number of shares of Stock and kind of securities subject to the Options then outstanding or subsequently granted, (ii)&nbsp;any
Purchase Price relating to the Option and (iii)&nbsp;any other provision of the Options affected by such change; <I>provided</I>, <I>however</I>,
that in the case of any &ldquo;equity restructuring&rdquo; (within the meaning of the Financial Accounting Standards Board Accounting
Standards Codification Topic 718 (or any successor pronouncement thereto)), the Committee shall make an equitable or proportionate adjustment
to outstanding Options to reflect such equity restructuring.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Change
in Control</U>. In the event of a Change in Control, each outstanding Option shall be equitably adjusted and assumed or an equivalent
Option substituted by the successor corporation or a parent or Subsidiary of the successor corporation. In the event that the successor
corporation in a Change in Control refuses to assume or substitute for the Option or the successor corporation is not a publicly traded
corporation, the Offering Period then in progress shall be shortened by setting a New Purchase Date and shall end on the New Purchase
Date. The &ldquo;New Purchase Date&rdquo; shall be a Trading Day determined by the Committee, in its discretion, which occurs before the
date of the consummation of the Company&rsquo;s proposed Change in Control. The Committee shall notify each Optionee in writing, at least
ten (10)&nbsp;Trading Days prior to the New Purchase Date (or such other date as may be specified by the Committee), that the Purchase
Date for the Optionee&rsquo;s Option has been changed to the New Purchase Date and that shares of Stock shall be purchased automatically
for the Optionee on the New Purchase Date, unless the Optionee has withdrawn from the Offering Period prior to such date, as provided
in Section&nbsp;6(c)(i)&nbsp;hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">12.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Return
of Accumulated Payroll Deductions.</U> In the event that the Optionee or his or her estate is entitled to the return of accumulated payroll
deductions, whether by reason of an election to discontinue and withdraw payroll deductions, termination of employment, retirement, death,
or, in the event that accumulated payroll deductions exceed the price of shares purchased or the limitations specified in Section&nbsp;6(d),
such amount shall be returned by the Participating Employer to the Optionee or his or her estate, as the case may be, as soon as practicable.
Accumulated payroll deductions held by the Participating Employer shall not bear interest (unless otherwise required by Applicable Law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">13.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Conditions
Upon Issuance of Shares</U>. Notwithstanding any other provision of the Plan, unless there is an available exemption from any registration,
qualification or other legal requirement applicable to the shares of Stock, the Company will not be required to deliver any shares of
Stock issuable upon exercise of a right under the Plan prior to the completion of any registration or qualification of the shares of Stock&nbsp;under
any local, state, federal or foreign securities or exchange control law or under rulings or regulations of any governmental regulatory
body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration,
qualification or approval the Committee will, in its absolute discretion, deem necessary or advisable. The Company is under no obligation
to register or qualify the shares of Stock with any state or foreign securities commission, or to seek approval or clearance from any
governmental authority for the issuance or sale of the shares of Stock. If, pursuant to this Section&nbsp;13, the Committee determines
that the shares of Stock will not be issued to any Optionee, any payroll deductions credited to such Optionee&rsquo;s account will be
promptly refunded, without interest (unless required by Applicable Law), to the Optionee, without any liability to the Company or any
of its Subsidiaries or Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">14.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Code
Section&nbsp;409A; Tax Qualification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Code
Section&nbsp;409A</U>. Options granted under a Section&nbsp;423 Offering are exempt from the application of Section&nbsp;409A of the Code
and Options granted under a Non-423 Offering are intended to be exempt from Section&nbsp;409A of the Code pursuant to the &ldquo;short-term
deferral&rdquo; exemption contained therein. In furtherance of the foregoing and notwithstanding any provision in the Plan to the contrary,
if the Committee determines that an Option granted under the Plan may be subject to Section&nbsp;409A of the Code or that any provision
in the Plan would cause an Option under the Plan to be subject to Section&nbsp;409A of the Code, the Committee may amend the terms of
the Plan and/or of an outstanding Option granted under the Plan, or take such other action the Committee determines is necessary or appropriate,
in each case, without the Optionee&rsquo;s consent, to exempt any outstanding Option or future Option that may be granted under the Plan
from or to allow any such rights to comply with Section&nbsp;409A of the Code, but only to the extent any such amendments or action by
the Committee would not violate Section&nbsp;409A of the Code. Notwithstanding the foregoing, the Company will have no liability to an
Optionee or any other party if the Option under the Plan that is intended to be exempt from or compliant with Section&nbsp;409A of the
Code is not so exempt or compliant or for any action taken by the Committee with respect thereto. The Company makes no representation
that the Option under the Plan is compliant with Section&nbsp;409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Tax
Qualification</U>. Although the Company may endeavor to (i)&nbsp;qualify an Option for favorable tax treatment under the laws of the U.S.
or jurisdictions outside of the U.S. or (ii)&nbsp;avoid adverse tax treatment (<I>e.g.</I>, under Section&nbsp;409A of the Code), the
Company makes no representation to that effect and expressly disavows any covenant to maintain favorable or avoid unfavorable tax treatment,
notwithstanding anything to the contrary in this Plan, including Section&nbsp;14(a)&nbsp;hereof. The Company will be unconstrained in
its corporate activities without regard to the potential negative tax impact on Optionees under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">15.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Enlargement of Employment Rights.</U> Neither the establishment nor continuation of the Plan, nor the grant of any Option hereunder, shall
be deemed to give any employee the right to be retained in the employ of the Participating Employer, or any successor thereto, or to interfere
with the right of the Participating Employer or successor to discharge the employee at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">16.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Tax
Withholding.</U> At the time an Optionee&rsquo;s purchase right is exercised, in whole or in part, or at the time an Optionee disposes
of some or all of the shares of Stock acquired under the Plan, or at the time of any other taxable event, the Optionee will make adequate
provision for any Tax-Related Items. In their sole discretion, the Participating Employer that employs the Optionee may satisfy any obligation
to withhold Tax-Related Items by (a)&nbsp;withholding from the Optionee&rsquo;s wages or other compensation, (b)&nbsp;withholding a sufficient
whole number of Shares otherwise issuable following purchase sufficient to pay the Tax-Related Items required to be withheld with respect
to the Shares as determined in the sole discretion of the Committee, (c)&nbsp;withholding from proceeds from the sale of Shares issued
upon purchase, either through a voluntary sale or a mandatory sale arranged by the Company, (d)&nbsp;requiring the Optionee to make a
cash payment to the Participating Employer equal to the amount of the Tax-Related Items, or (e)&nbsp;any other method permitted under
Applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">17.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Governing
Law.</U> The Plan and all Options and actions taken thereunder shall be governed by and construed in accordance with the laws of the Commonwealth
of Massachusetts, U.S.A., without regard to the conflict of laws principles thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">18.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Definitions.</U>
As used in this Plan, the following terms shall have the meanings set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Affiliate&rdquo;
will have the meaning ascribed to such term in Rule&nbsp;12b-2 promulgated under the Exchange Act. The Committee will have the authority
to determine the time or times at which &ldquo;Affiliate&rdquo; status is determined within the foregoing definition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Applicable
Law&rdquo; means the requirements relating to the administration of equity-based awards under state corporate laws, U.S. federal and state
securities laws, the Code, the rules&nbsp;of any stock exchange or quotation system on which the Common Stock is listed or quoted and
the applicable laws of any non-U.S. jurisdiction where Options are, or will be, granted under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in"> (c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Board&rdquo; means the Board of Directors of the Company.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Code&rdquo;
means the U.S. Internal Revenue Code of 1986, as amended, or any statute successor thereto, and any regulations issued from time to time
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Committee&rdquo;
means a committee of the Board appointed by the Board from time to time to administer the Plan in accordance with Section&nbsp;3 to serve
at its pleasure for the purpose of carrying out the responsibilities of the Committee under the Plan. For any period during which no Committee
is in existence, all authority and responsibility assigned the Committee under this Plan shall be exercised, if at all, by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Company&rdquo;
means Boston Scientific Corporation, a Delaware corporation (or any successor corporation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Compensation&rdquo;
means, unless otherwise determined by the Committee, the total salary or wages or other taxable compensation (such as bonus payments,
commissions, short-term disability payments and wage or salary substitution payments) paid by a Participating Employer to the Optionee
during active employment (including approved paid leaves of absences) as of a particular pay date, exclusive of expense reimbursement,
relocation allowances, tuition reimbursement, adoption assistance benefits, earnings related to stock options or other equity incentives,
and post-employment payments that may be computed from eligible compensation, such as severance benefits, salary continuation after termination
of employment, redundancy pay, or termination indemnities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Change
in Control&rdquo; means any of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">any
 &ldquo;person,&rdquo; as such term is used in Sections 13(d)&nbsp;and 14(d)&nbsp;of the Exchange Act (other than the Company or any corporation
owned directly or indirectly by the stockholders of the Company in substantially the same proportion as their ownership of stock in the
Company) is or becomes the &ldquo;beneficial owner&rdquo; (as defined in Rule&nbsp;13d-3 under the Exchange Act), directly or indirectly,
of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company&rsquo;s then outstanding
securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">an
acquisition, consolidation or merger if all or substantially all of the beneficial owners of the outstanding Stock of the Company and
the combined voting power of the outstanding voting securities of the Company entitled to vote generally in the election of Board members
immediately prior to such transaction do not own beneficially, directly or indirectly, and in substantially the same proportion, more
than 50% of, respectively, the then outstanding shares of Stock and the combined voting power of the then outstanding voting securities
entitled to vote generally in the election of Board members, as the case may be, of the corporation resulting from such transaction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">a
sale or transfer of all or substantially all the Company's assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">a
dissolution or liquidation of the Company; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">if,
over a period of twenty-four (24) consecutive months or less there is change in the composition of the Board such that a majority of the
Board members (rounded up to the next whole number, if a fraction) ceases, by reason of one or more actual or threatened proxy contests
for the election of Board members, to be composed of individuals who either (i)&nbsp;have been Board members continuously since the beginning
of that period, or (ii)&nbsp;have been elected or nominated for election as Board members during such period by at least a majority of
the Board described in the preceding clause (i)&nbsp;who were still in office at the time that election or nomination was approved by
the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding clauses (i)&nbsp;through (v)&nbsp;above, none of the
following shall constitute a &ldquo;Change in Control&rdquo; for purposes of this definition:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
shares of Stock or the voting securities of the Company entitled to vote generally in the election of Board members are acquired directly
from the Company in a capital raising transaction;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
shares of Stock or the voting securities of the Company entitled to vote generally in the election of Board members are acquired by any
employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">(A)&nbsp;the beneficial owners of the outstanding
shares of Stock, and of the securities of the Company entitled to vote generally in the election of Board members, immediately prior to
such transaction beneficially own, directly or indirectly, in substantially the same proportions immediately following such transaction
more than 50% of the outstanding shares of Stock and of the combined voting power of the then outstanding voting securities entitled to
vote generally in the election of the members of the board of directors of the corporation (including, without limitation, a corporation
which as a result of such transaction owns the Company or all or substantially all of the Company's assets either directly or through
one or more subsidiaries) resulting from such transaction and (B)&nbsp;at least a majority of the members of the board of directors of
the corporation resulting from such transaction were members of the board of directors at the time of the execution of the initial agreement,
or of the action of the Board, authorizing such transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Eligible
Employee&rdquo; means, unless otherwise determined by the Committee in connection with a particular Offering Period, an Employee who is
customarily employed by a Participating Employer for twenty (20) or more hours per week. The Committee, in its discretion, from time to
time may, prior to an Enrollment Period for all Options to be granted in an Offering Period, determine (on a uniform and nondiscriminatory
basis for the Section&nbsp;423 Offerings) that the definition of Eligible Employee will or will not include an individual if he or she:
(A)&nbsp;has not completed at least two (2)&nbsp;years of service since his or her last hire date (or such lesser period of time as may
be determined by the Committee in its discretion), (B)&nbsp;customarily works not more than five (5)&nbsp;months per calendar year (or
such lesser period of time as may be determined by the Committee in its discretion), (C)&nbsp;is a highly compensated employee within
the meaning of Section&nbsp;414(q)&nbsp;of the Code, or (D)&nbsp;is a highly compensated employee within the meaning of Section&nbsp;414(q)&nbsp;of
the Code with compensation above a certain level or who is an officer or subject to the disclosure requirements of Section&nbsp;16(a)&nbsp;of
the Exchange Act, provided the exclusion is applied with respect to each Section&nbsp;423 Offering in an identical manner to all highly
compensated individuals of the Participating Employer whose employees are participating in that Offering Period. An Optionee shall be
deemed to have ceased to be an Eligible Employee either upon an actual termination of employment or upon the corporation employing the
employee ceasing to be a Participating Employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(j)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Employee&rdquo;
means an individual treated as an employee of the Company or other Participating Employer under their payroll records or for purposes
of Section&nbsp;423 of the Code. The Company shall determine in good faith and in the exercise of its discretion whether an individual
has become or has ceased to be an Employee and the effective date of such individual&rsquo;s employment or termination of employment,
as the case may be. For purposes of an individual&rsquo;s participation in or other rights, if any, under the Plan as of the time of the
Company&rsquo;s determination, all such determinations by the Company shall be final, binding and conclusive, notwithstanding that the
Company or any governmental agency subsequently makes a contrary determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(k)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Enrollment
Agreement&rdquo; means such written or electronic agreement described in Section&nbsp;6(c), in such form as may be approved by the Committee
from time to time, whereby an Eligible Employee elects to participate in the Plan and authorizes a Participating Employer to withhold
payroll deductions from his or her Compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(l)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Enrollment
Period&rdquo; means the period during which Eligible Employees may elect to participate in the Plan, commencing approximately 45 days
prior to the beginning of each Offering Period and ending approximately 10 days prior to such Offering Period (or such other period as
may be established by the Committee).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(m)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Entry
Date&rdquo; means the first Offering Commencement Date on or after the date on which an Employee becomes an Eligible Employee.</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(n)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Exchange
Act&rdquo; means the U.S. Securities Exchange Act of 1934, as amended from time to time, or any successor law thereto, and the regulations
promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(o)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Fair
Market Value&rdquo; means, with respect to the Stock on a given date, the closing price as quoted on the New York Stock Exchange on such
date (or if there shall be no trading on such date, then on the immediately preceding date on which sales were made on the New York Stock
Exchange, or such other appropriate date as shall be determined by the Committee).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(p)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Non-423
Offering&rdquo; has the meaning assigned to it in Section&nbsp;1 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(q)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Offering
Commencement Date&rdquo; means the first Trading Day of each Offering Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(r)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Offering
Period&rdquo; means, unless determined otherwise in accordance with Section&nbsp;6(a)&nbsp;hereof, the consecutive six (6)&nbsp;month
period beginning each January&nbsp;1<SUP>st</SUP> and July&nbsp;1<SUP>st</SUP> of each calendar year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(s)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Option&rdquo;
means an option to purchase shares of Stock granted under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Optionee&rdquo;
means an Eligible Employee who has elected to participate in the Plan and to whom an Option is granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in"> (u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Option Shares&rdquo; means shares of Stock subject to an Option.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(v)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Participating
Employer&rdquo; means the Company or any Subsidiary or Affiliate designated by the Committee to participate in the Plan as of an Offering
Commencement Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(w)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Plan&rdquo;
means this Boston Scientific Corporation Employee Stock Purchase Plan as set forth herein (and formerly known as the Boston Scientific
Corporation 2006 Global Employee Stock Ownership Plan), as it may be amended or restated from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(x)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Purchase
Date&rdquo; means the last Trading Day of each Offering Period.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(y)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Stock&rdquo;
means the common stock, USD&nbsp;0.01 par value per share, of the Company.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(z)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Section&nbsp;423
Offering&rdquo; has the meaning assigned to it in Section&nbsp;1 hereof.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(aa)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Sub-Plans&rdquo;
has the meaning assigned to it in Section&nbsp;3(c)&nbsp;hereof.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(bb)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Subsidiary&rdquo;
means a subsidiary corporation of the Company, whether now or hereafter existing, as &ldquo;subsidiary corporation&rdquo; is defined in
Section&nbsp;424(f)&nbsp;of the Code.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-size: 10pt">(cc)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Tax-Related
Items&rdquo; means any U.S. federal, state, and/or local taxes and/or any non-U.S. taxes (including, without limitation, income tax, social
insurance contributions (or similar contributions), payroll tax, fringe benefits tax, payment on account, employment tax, stamp tax and
any other tax or tax-related item related to participation in the Plan and legally applicable to an Optionee, including any employer liability
for which the Optionee is liable pursuant to Applicable Laws or the applicable Enrollment Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(dd)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;Trading
Date&rdquo; a day on which the principal exchange that Stock is listed on is open for trading.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(ee)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">&ldquo;U.S.&rdquo;
means the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>bsx-20220503.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWamECbOdzZR+aYkxtmB9bQmqnykrID/iniXg7PuW0ZML -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:bsx="http://bostonscientific.com/20220503" elementFormDefault="qualified" targetNamespace="http://bostonscientific.com/20220503">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://bostonscientific.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="bsx-20220503_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bsx-20220503_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bsx-20220503_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="bsx_SeniorNoteDue2027Member" name="SeniorNoteDue2027Member" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="bsx_A550MCPSSeriesAMember" name="A550MCPSSeriesAMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>bsx-20220503_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bostonscientific.com/role/Cover" xlink:href="bsx-20220503.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bostonscientific.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems" xlink:label="loc_deiEntityInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="bsx-20220503.xsd#bsx_SeniorNoteDue2027Member" xlink:label="loc_bsxSeniorNoteDue2027Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_bsxSeniorNoteDue2027Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="bsx-20220503.xsd#bsx_A550MCPSSeriesAMember" xlink:label="loc_bsxA550MCPSSeriesAMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_bsxA550MCPSSeriesAMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bsx-20220503_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bsx-20220503.xsd#bsx_SeniorNoteDue2027Member" xlink:label="bsx_SeniorNoteDue2027Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bsx_SeniorNoteDue2027Member" xlink:to="bsx_SeniorNoteDue2027Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bsx_SeniorNoteDue2027Member_lbl" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bsx-20220503.xsd#bsx_A550MCPSSeriesAMember" xlink:label="bsx_A550MCPSSeriesAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bsx_A550MCPSSeriesAMember" xlink:to="bsx_A550MCPSSeriesAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bsx_A550MCPSSeriesAMember_lbl" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems" xlink:label="dei_EntityInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationLineItems_lbl" xml:lang="en-US">Entity Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bsx-20220503_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bostonscientific.com/role/Cover" xlink:href="bsx-20220503.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://bostonscientific.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems" xlink:label="loc_deiEntityInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiEntityInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bsx-20220503.xsd#bsx_SeniorNoteDue2027Member" xlink:label="loc_bsxSeniorNoteDue2027Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_bsxSeniorNoteDue2027Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bsx-20220503.xsd#bsx_A550MCPSSeriesAMember" xlink:label="loc_bsxA550MCPSSeriesAMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_bsxA550MCPSSeriesAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2214421d1_ex10-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2214421d1_ex10-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !4 -,# 2(  A$! Q$!_\0
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M:'IMM!9D_NY;]F#2C^\%'W1]:\XOHHY_BDT,J!XY-5574]&!D (/X5[L%"J
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M8X' [K71ZU?ZQ;L\5AHR7<!ARTS7:Q%3SD;2#G P<^]>4>#AGXHPC_IXN/\
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# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2214421d1_ex10-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2214421d1_ex10-1img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !8 +(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W/4M3M-)M
MOM-[+Y4.X+NVEN3T& #3=,U>RUB!IK&=9D5MK8!&#]" :R_&,%Q/I, MHYW=
M;J)SY,9=E /)  /2L*.WU-+2_E2/4O)FNX6EN#&8[F2, A\*.>..@Y!- '?9
MIID4.$W#<1D#/)K@GBU3^S9/GU+[&+MC;I*)-[1E> Y4[PN>G'U[58@L[Y=:
MTF]>*]%PU@Z@2NSJL@ P'(&!D<G('/O3L*YV^: <UP$::N(7%E_:9?[#*+W[
M1OSY^WY?+SU.[^[QBMO1+6\LM6".]Z\$MA')(9V9@)LX(R>AQVH"YHZCXATW
M2[@0W=SL? 8@(S;0>A. <#ZUHJX901C!Z$=ZXW6TN;?6KV>TBO$N)HT 18//
M@N\# #<?+CIU]_K.4OVU^(WB7\9#0?9TM,F$+C]X'_AQG.<\X QFBP7.ELKZ
M#4+5;FV?S(7)"L 1G!(/7W!JQFO.[E-<.E:8LIU%$_?^:460R;]YV;@OS=,8
MSQ5F>RUF2QO99)M2-S!:0-!Y;.N^3#;OE'4\#(HL%SL[N^M[&VEN+B54BA7=
M(>3M'T'-4YO$6F6\LD<MQ@QQK(^V-FVJQ 7.!WR.*Y6ZL[V&ZUB=$U+[9/:Q
MR0>5O*EL?,..,@\ =LTITW4(?[<N8EU 3NMJ(RN_+Y"%R/4C!'MR*+!<[W/M
M6?J>MV.D",WLWE^9G8 C,3@9)P >!ZUAVL=]_P )9*]P=4#"=]@C!-L8=HVY
MR<9SGISFK&H&33?%(U.:WGN+62S\A?)B,A5PV[&!S@CO2&;]M=0W=M'<6\@D
MBD7<C+T(J7/%<9J2W;VMH39WUC:FVD*06&=R3D_*&"8XQSZ9)S5*:#7!%>7%
M[<7\+6^EA_D=@CR[&!R1P3WX[_A3L*YZ!N]*,UPVB-?R6ZR6+W\DKZ<QF:Z9
MBAF(!CV$\'OT[8J*)-26PU#[#_:[+]A7/VG?O^T9YV9YZ9SBBP7.^S4%S>V]
MG!+-/(J)"N^3N57UP.:Y#7K;4K?R[:V?4YS%:N\<REFWR[L\[,8./7(YP :@
MFL+VVUGQ%-''?":>S#6[IO(9MO(!'<'@#MVHL%SO%<.@93D$9%+FN%OTU8ZE
M='.I_:]\/V$1%O)V\;MV./7.:DO;?5EOS>0-J)8:NJ+&I?9Y&P$G;TVY[]*
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M,CO6?)KEC#*8WE(/V8W1../+&._KR.*:GB"P9(V+NN^X^S;67!#^X[=N?<4
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KR\+_ .0Q^=6[.R%I+>.'+?:9_.((^[\BKCW^[^M%% %NBBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140717687768232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 03, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  03,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNoteDue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX PR A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNoteDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNoteDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>tm2214421d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://bostonscientific.com/20220503"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bsx-20220503.xsd" xlink:type="simple"/>
    <context id="From2022-05-03to2022-05-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="From2022-05-032022-05-03_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="From2022-05-032022-05-03_custom_SeniorNoteDue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNoteDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="From2022-05-032022-05-03_custom_A550MCPSSeriesAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-05-03to2022-05-03">0000885725</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-05-03to2022-05-03">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-05-03to2022-05-03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-05-03to2022-05-03">2022-05-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-05-03to2022-05-03">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-05-03to2022-05-03">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-05-03to2022-05-03">1-11083</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-05-03to2022-05-03">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-05-03to2022-05-03">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-05-03to2022-05-03">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-05-03to2022-05-03">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-05-03to2022-05-03">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-05-03to2022-05-03">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-05-03to2022-05-03">683-4000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-05-03to2022-05-03">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-05-03to2022-05-03">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-05-03to2022-05-03">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-05-03to2022-05-03">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-05-03to2022-05-03">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="From2022-05-032022-05-03_us-gaap_CommonStockMember">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-05-032022-05-03_us-gaap_CommonStockMember">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-05-032022-05-03_us-gaap_CommonStockMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-05-032022-05-03_custom_SeniorNoteDue2027Member">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-05-032022-05-03_custom_SeniorNoteDue2027Member">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-05-032022-05-03_custom_SeniorNoteDue2027Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-05-032022-05-03_custom_A550MCPSSeriesAMember">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-05-032022-05-03_custom_A550MCPSSeriesAMember">BSX PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-05-032022-05-03_custom_A550MCPSSeriesAMember">NYSE</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ W8.F5)>*NQS     $P(
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M_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ W8.F5"0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( -V#IE1ED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    " #=@Z948VYT/^X    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #=@Z94
MF5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( -V#IE1![/RP(04  %X6   8              "
M@0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #=@Z94
MGZ ;\+$"  #B#   #0              @ %D#0  >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( -V#IE27BKL<P    !,"   +              "  4 0  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( -V#IE2JQ"(6,P$  "("   /
M      "  2D1  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #=@Z94)!Z;
MHJT   #X 0  &@              @ &)$@  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " #=@Z9499!YDAD!  #/ P  $P
M    @ %N$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  "X
%%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2214421d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bostonscientific.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2214421d1_8k.htm">tm2214421d1_8k.htm</File>
    <File>bsx-20220503.xsd</File>
    <File>bsx-20220503_def.xml</File>
    <File>bsx-20220503_lab.xml</File>
    <File>bsx-20220503_pre.xml</File>
    <File>tm2214421d1_ex10-1.htm</File>
    <File>tm2214421d1_ex10-2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2214421d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 4,
   "dts": {
    "definitionLink": {
     "local": [
      "bsx-20220503_def.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2214421d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20220503_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20220503_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20220503.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 66,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 2,
   "memberStandard": 1,
   "nsprefix": "bsx",
   "nsuri": "http://bostonscientific.com/20220503",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2214421d1_8k.htm",
      "contextRef": "From2022-05-03to2022-05-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://bostonscientific.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2214421d1_8k.htm",
      "contextRef": "From2022-05-03to2022-05-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "bsx_A550MCPSSeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "5.50% MCPS, Series A [Member]"
       }
      }
     },
     "localname": "A550MCPSSeriesAMember",
     "nsuri": "http://bostonscientific.com/20220503",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SeniorNoteDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Note due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorNoteDue2027Member",
     "nsuri": "http://bostonscientific.com/20220503",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001104659-22-057017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-057017-xbrl.zip
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M=-F1AZ&%_FN9D@V>Q_9YK^9:'!UDW.E[&\?7:\YBME_3^23H6QGZ!K859[:
M)147!F_ &.S4_FBO=I#"Z0,/,\P(%]^XPI<1UM_^",JKT0#XP799MT+@&LY@
M-_6J$H_/S@9?)[>S&18$RW&5P%;H@^WB:XN\,&.P*WF54;G9E#Q+!>[U6>V3
M\#SBX<RQT$?-5VUD(8U?I;=N)O%8$PH-J6N*EG:-"Y#6BWS(]DVGET>J?(EE
M(,A&Y:;3@-@Y9'<T+Y,&>VCW?<@=7A*I1!S+?K95W:E8B[3>C'KV8-?NWI4Q
M8Q&B=WC#18T9>61G/#@@#4G_P;WT_XJ04%C071/U2^#.&&#C#7EP]@X3&X%T
M_FB":6)"&=T9%ZS$(1O^[MZ&V0I3:A[$(M;H:CC$=\8*@#IDQH_O:\;5DYE4
MZ+&KN1_[(IVTI,@><N4?[EVYU0DB#_4\0C3PHP3NC!,VWI '']_+@RL6-G4@
MA79,_SSKJL<YKN6_)C) -.%XK8\!SP5!>&=LL#-_]1N:?]J*_V D&ANQ!W?,
MAB)OT 2'&?4D$J) K[)'@M"MMZ&2..B#PQPZB<:L(OP6 ?>D]S&_H%JONY4P
MJ+?#Q#DAEMU68<HLF*S2O(CLB.X6TJ#V#A/FA-Q$7X\"T2D+\?97O*L2OP3M
MB/HVUJ#\#A/EA-VM(&LD=C,2U'<X96Q'#+#2!AUPF!TG].[1=AJF"^KBB.J-
M (ITQ(\J]J M#M/C+*2 BPW/W6N?\$A?R;L)#RN'B,J"';&H/@;0*(<Y=,)U
M'(8"2YG^9V(;5MEC@7?$%(@Y^$#.83X-,1P=9\6HLU:,JJUPF$]##$^/L^*T
MLU:<5EOA,*LN,)SHCS?BGC\#JP0 <+=L*/$&37">4J?\XK'L1MP*_D22+6!U
M3I1*=,L.&WG0$^=I=]9FDJE%DZLB07;+@SQI4'OG:7=*[I9+A>A_R:9N5FO#
M=\N'0^J@&PZS\+1UF%LTT/*Q J3UFA^R!65VF&J;<6DL,(*;>1[1?I'+9$&-
M'>;-7[AYPK3BK/+>=1G5>JVMA$&]7::_9JNF!+N-_=>M5[C(%)+V=?:[-)/V
M=T&4YF1V@40LO4L%/)&T0ELO.<P:E-]A"COCE 1:*;;\JN>O@B!JU_X0UWKA
M <J@Z@ZSU5N!37O .E&(%_B9?>#B9K& >G(8WWH7:JB#;CA,6TL4IU)&6!SK
MR4&IKCEC#P#TQV$*.\-!I#O1W7 TOS?O.P!ZJ!*J]?I;"8-Z.TQ;O_%[@<Q;
MFV:[]9Q3>&N3!=AZU2'.H/ .,]0",[OD!4CKQ3YD"\KL,$/-+KRK;;!";(GA
ME2@V9.M%!TF#VCO,7%\ZO66COGS9M;Y\V: O=YBY9L22S0KZ6KR94[)$\ [*
MB@*=<0'B#AGRP>6.X7A/6RZ@:_W!;H45VGH38-:@_"ZW$D<A43A,2%X3AEB@
M$\/]!D_@SD-=J?:;TB0 T!_GSW%_QY3^RO@SFV$D.<-ADIQ4/34!BK3>F7KV
MH"W.G^Q^YS1B"HEX>;&H?+%;"=H1&VRL0?F=/\1-E]3O1[?D9;-5+MA+=,2,
M"O*@)\X?[DZ9P@(%BCSA2Z10RKG*$WN)CGA201[TQ/E"Z_CBG>BA;<FKUSH4
M@!UQX) S*+SS]=6S-:+T<R1U$+*R7RH .R+\(6=0>.<KJ*_66"QU%_F+X,]J
ME6Z&KC+ 6J C1L#<04.<KY2^VKZ\M"'9"5KIQ@&Z*U;8B4,^V()Z*Q_V[Y )
M K-,)ID_L! )P D8WWHO:JB#;CA,NV_4"HO\3"ZF9P*J6L!25ZKUSC0* /3'
M>=J=?Y5&Y?"=P[7> X RJ+KSK/HVFE,27%..*O.&'*PCFI<9@Y([SZ0_(_8H
MHHT*=K>"!QB;AU1R?YTV2.(:G: C-C6/!330_5;FEY<&SU9(8'D3J?CO"FG&
ME3=$*LIUQ*[:$$"7WN'58/)E>R,./^_N\ (+L^#D'F_59UW98_5DK+9XZST[
M+A+0NEPJ_ZE?"E)7_ZB_2X^;'^:/(NDC_P=02P,$%     @ W8.F5#O"B (,
M#   89(  !0   !B<W@M,C R,C U,#-?;&%B+GAM;,V=86_;N!G'WP_8=^#Y
M,& #ZCAVE@W-M7=(T^007)ID==K;5@P%+=&.$%G,*#EQOOV1E"A+)!])R?5(
M]D7J2/^'^E/\A:1DZM&;G[;K%#T0EB<T>SN:[NV/$,DB&B?9ZNWHTWQ\/#\Y
M/Q^AO,!9C%.:D;>CC(Y^^O'/?T+\WYOOQF-TEI T/D+O:30^SY;T!W2)U^0(
M_4PRPG!!V0_H,TXW8@L]2U+"T E=WZ>D('Q'>> C=+@WG45H/!Y0[F>2Q91]
M^GA>EWM;%/?YT63R^/BXE]$'_$C97;X7T?6P N<%+C9Y7=K^=K_Z5X:_29/L
M[DC\6."<('Z^LOQHFR=O1^*XU6$?#_8H6TUF^_O3R;\_7,RC6[+&XR03YRTB
M(Q4E2K'%35^_?CV1>Y744&X7+%7'.)@H.W7)?&_2H6\XR9.C7-J[H!$N9+/W
M'@:!"O';6,G&8M-X.AL?3/>V>3Q2)U^>0493\I$LD:SF4?%TSU'*$T'"J-IV
MR\C2;B9E;"+B)QE9X8+$XD"OQ8&F_Q '^K[:?($7)!TAH>1\@/5ZW2JK"IJX
M-GM-6$+CT^QEKO5H3_;YWPXK?D<%FO'.JW!#"YR^R'PSTKGM2_*R,[Z+<W^F
M>3]/7G:F&Y%_B.W"M/SLTVL_KZG8>,$_M2R2;<$',!(KDZ*(CAY8'D$.#%79
M=>DT:I6;BMZ<,K/N8F2492YQOI %;_+Q"N-[?H#9=$+2(E=;QF++>']:]=_?
M5YN_BA&2K$E6G*0XSZ^6\X)&=\?;)%='DU5].QJ@G^C5$)''3-4%LZCGA%2*
M243Y<'9?C-/RU)?A2T;7@VQ49XX.$']-%W7YY:GF%H"*M&2,Y'3#(O*LEF[6
M9NA9K1RN4QXAIFTD&W^:CWZ4,D272 K1%R']WYO)KFB/1/$IX)IFTM@'LEX0
M!M39HG-)$&BS28XA"H88R)E!BM0I3DKI[R9ED6]%Z\_V#_</9-OS#5_G)$LH
MNZ0%>;\A?.\_K:W?J731_@.L"@(Z9-X9Z/>F4U"JD9"C>$.0"/AC:3@^/-S_
M<'(]G_.Y(,F/018 G2L2.FTJ#JRB("CH<J8S<+AWN/\7)-2O4*E'Q]^,@6\]
M&[G!B]UD#QHL*Y&7>4?+H'6R(17>*>FT97032H2^2-FWQ2(GT=Z*/DQBDD@B
M_O]W\7%<?I08\%^_GF9%4CR)FSAL+>]A\&DV.>>V]!EIG]@%%L,,"SRZE=XQ
M&61/QZ4,0(T(]$7$(!GD Y[W--I(R'FIEAJV=[L"Q&9*(='<%P0$%D-ZLRL)
M$AH/C7S,#QX+ V<I7EFJH.UWU<Q66ZJ=6SN#:&B;([VE:PT2(I]-_9[D$4ON
M11_359>6S'G#6TP:[=_0A(6!:0RFH:'UV,E_)*LD+Y@<>.J92T>7!NA=#P.=
MMO5QP2H. IPA#L&1HQF$ZBB/+!UGV0:G'\D]95T(M66NR;&9U(%I:H+BQ&(,
MQ*/4HE+LD8I_;3 K"$N?>L$PE*[9 *SJ>&BRH BQ>P,AJ>7^.;EA.,L3T9GU
M@F)*G5^& &:-2Q)-%Q0K@#GX4J76^Z=E?DO25"R4P5E_QV(3NR8&-JPS8RJ#
MH@:T!W(C(U 5$A8ZIP]BULZG3@,KW-#[!,BPW<50+0X6(]WA0))D&!)Q'FEJ
MK-/IX<A0NB8(L*JSH\F"HL;N#>2EE".I#P.4TRP>A$FM\P.)9M..2"4*$)"V
MLSX\N-HW'&=)'N&T]'/&M]F^I^G0NH8$M*N#8@B#@@5R!P)3!BAN9(AW:/Y#
M,!N&3$/I!QC#JAV76A8@++JW/E2$WALH)QO&6L[AT0>6ND*ESZQB!=(% 4N/
M.6-A62EOP>)Q-"J_BQ8/H5QN+$N-[!*W2P1,<^V% ;O]0?  F (6 0@=*H7>
M6E]]JY 5XND?L$JZS"T%=I-M$MJ:@&BP&@.(V&GEPUC>J#CAO13#Z7D6D^TO
MY FLFZ%SRP5@LPV&)@J(#+LS (U*C*0:<;DW.*Y9LL;L:9Y$/<.&*72+!V2T
MS8>N"@@0P!I 2*5&\_,3WZ/*#=Z>QQS89)F4#U7VD +JW0+38[O-#2 .")]N
MAP!%/ BUHWS#=)Y%E-W3QG*)$[KAG>'3"8WA&4M/E.N5K@.JH"]Y[0@)"+(A
M/L%%L(W05^6:%D3% _&R "1*\$;=<1SSDY57_UTD&9F"Y\"J=4M8A]TV5Q9A
M0#3![@"&*N4K]0&)&'25A03.[!G5G?D'9S84G%G0X,Q> L[-(PT(G(-G5/?
M/S@'0\$Y"!J<@Q>!PQO?>Y]SPC]>L1OZ:%OP#2J]8&-:M4*SDX6'C.&M#Q@1
M(.8W(L0W*G*R=<6N&7U(L@B>1D-R+]  IJWD:-KP\+$;[&.HGB2K.-\@59/U
MWC\6)?/3V[1-VKN:4A,>*&UCO9U,J?:-Q37-"YS^-[GOO$BWB[T@8C5L!:6E
M# \7F[T^:,H8Q(-\7717V(HO0*R/JVG[G7U+;;-5?S7=W!D$"#9'9G:3\NY*
M*?+1U()51C#0,[1W.VMHBZFZG1O[PFAFTY#1RO+OFVM\_4&+=(KI]2W-X,4%
MIL15:T/F5(OK^X-H=<"4WO)2AJ3.XYU[D=8MMW?EC7W.1GK=3CVPJQU!M+#N
MQABVU7X/+?HK2PI^=)$;:Y-5WPS9UB ".E<MW6E3M;I5% 0!7<YT&BHM:HL]
MH#&G:1(E19*M/O"+4Y9@6\UL(E=0P 85$:8B"!Q 6T86HEJ(E-(#"->,"!@)
M;PSYP*'([,FNEDOKZ-\E=@5&OV$%"*P, I1>>SHP/& <-2)0&8)DC']TSO-\
M0]BS +*$>,((- _ 9.A#1 HRV0M6&>B;KSF)-GR\?)K.%C=)8>3)LTN<C4^
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M82K'8AVX2\/IX[9[N8CC5Y*FOV3T,9L3G-.,Q.7]%MNW2]UZMZMN>FRW%]X
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M%$&[-CZW<PE21[2D)T1*^ V=2U7AQ"X2[0KZ7 /*B"+J_F=*E*&*+R'2%\!
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MQU4\Q6Y_3'@!/03^=]IO:N'67,"9%+SU&SHDT9;EWJAQ2R9-UM![P> F.#Z
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M F]Y$\:;)J%K4EO>A/#FV#(?,#V*9R1H%D$B9U+*.^[SK#L$[SH3T5KMYI[
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MJID*_I$E_ZF+W;VCE_O%?!'ER[W'1R__4=*'F\-!7.0Z352I Q >2FL<)\J
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MFR&#,^.=]&.,JW?-(/?TSIY<M7;=K(72LG&#5RVL)S>*J&6-PNJ*0*ZB/IR
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MCQCDT/@DL1D.94]+COY('5@G,<^E8@\'<,2YX@I,T;@H11N.U;HG_7=>&AA
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MW.MO?Q'4W;P(?<S04L0*RM*BOJC\3X$Y]=I8>9Z1%N-$D8NX!NR/SM*)<OY
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MLZ.DD>HM:TQ0KVH+-A=J5.VZ%4VPG/=V3ULM]N?1#LFVM-D[0ZM"MLE_P)[
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M828F9Q5^ZX1@3_J&[\3JRF>&*2SP.^S1OO<WWCL.<.9 3>RPI-_BF;/1[WP
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ML2N?!$[*TW_@^ 7"W<7S.YD!]V4;O@!%QSK/X7N<4&.]N>2SKTVX-'UK,-9
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M8-46^,@"6?G<&?-H[[%2DTR$A+2C)"3'/1)<SIQF[DV6'V+V+/YE7G73-MV
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MLM:9*V@\'!U:AYN421V/@ LVXC=S0D7G&FV80/RZ/>MR*C*PZ^<;/0S,S>7
M>R@_6W#->PBLK%"B(D-17)%RH35+C\7M 7]DO\F71N%\3&>$U\%LC@<' [7
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M<+XDQ6,D_AY7OGTXF:OJR1)]E_A\6Z&:OUFIDS16EYR "0@>QB*[@F4 3AG
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MJV07;^3EWA*]K^/1Y1O+*%"^1=:19M%0\Q@-%0287:#. _%]9<64(!S*B\V
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MQ&T.DF.5Q&Y1F%B9;*=6UIYEB,9#Z<.8LLF^O8UUMZG([*HJ>SH=/R*IP<J
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MQ6PA&&J4"V^;N42#]_F2';OW'X  63=8P$FUC'!A:)(1U/XJZKM$I0C+>7_
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M+3(P,C(P-3 S+GAS9%!+ 0(4 Q0    ( -V#IE02K\G*%PD  )%K   4
M          "  0 $  !B<W@M,C R,C U,#-?9&5F+GAM;%!+ 0(4 Q0    (
M -V#IE0[PH@"# P  &&2   4              "  4D-  !B<W@M,C R,C U
M,#-?;&%B+GAM;%!+ 0(4 Q0    ( -V#IE3+"X;74P@  "5F   4
M      "  8<9  !B<W@M,C R,C U,#-?<')E+GAM;%!+ 0(4 Q0    ( -V#
MIE0:JH((^QT  )[L   2              "  0PB  !T;3(R,30T,C%D,5\X
M:RYH=&U02P$"% ,4    " #=@Z94OR(-V40X   ]*P$ %@
M@ $W0   =&TR,C$T-#(Q9#%?97@Q,"TQ+FAT;5!+ 0(4 Q0    ( -V#IE3#
M!GL Z3T  "%1 0 6              "  :]X  !T;3(R,30T,C%D,5]E>#$P
<+3(N:'1M4$L%!@     '  < S $  ,RV      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
